Skip to main content
Top
Published in: The Journal of Headache and Pain 2/2012

Open Access 01-05-2012 | Guidelines

Italian guidelines for primary headaches: 2012 revised version

Authors: Paola Sarchielli, Franco Granella, Maria Pia Prudenzano, Luigi Alberto Pini, Vincenzo Guidetti, Giorgio Bono, Lorenzo Pinessi, Massimo Alessandri, Fabio Antonaci, Marcello Fanciullacci, Anna Ferrari, Mario Guazzelli, Giuseppe Nappi, Grazia Sances, Giorgio Sandrini, Lidia Savi, Cristina Tassorelli, Giorgio Zanchin

Published in: The Journal of Headache and Pain | Special Issue 2/2012

Login to get access

Abstract

The first edition of the Italian diagnostic and therapeutic guidelines for primary headaches in adults was published in J Headache Pain 2(Suppl. 1):105–190 (2001). Ten years later, the guideline committee of the Italian Society for the Study of Headaches (SISC) decided it was time to update therapeutic guidelines. A literature search was carried out on Medline database, and all articles on primary headache treatments in English, German, French and Italian published from February 2001 to December 2011 were taken into account. Only randomized controlled trials (RCT) and meta-analyses were analysed for each drug. If RCT were lacking, open studies and case series were also examined. According to the previous edition, four levels of recommendation were defined on the basis of levels of evidence, scientific strength of evidence and clinical effectiveness. Recommendations for symptomatic and prophylactic treatment of migraine and cluster headache were therefore revised with respect to previous 2001 guidelines and a section was dedicated to non-pharmacological treatment. This article reports a summary of the revised version published in extenso in an Italian version.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ad Hoc Committee for the Diagnostic and Therapeutic Guidelines of Migraine and Cluster Headache (2001) Diagnostic and therapeutic guidelines for migraine and cluster headache. Italian Society for the Study of headaches (SISC). J Headache Pain 2(Suppl. 1):105–190 Ad Hoc Committee for the Diagnostic and Therapeutic Guidelines of Migraine and Cluster Headache (2001) Diagnostic and therapeutic guidelines for migraine and cluster headache. Italian Society for the Study of headaches (SISC). J Headache Pain 2(Suppl. 1):105–190
2.
go back to reference Ferrante E, Rossi P, Tassorelli C, Lisotto C, Nappi G (2010) Focus on therapy of primary stabbing headache. J Headache Pain 11(2):157–160 (epub 2010 Jan 30; review)PubMedCentralPubMedCrossRef Ferrante E, Rossi P, Tassorelli C, Lisotto C, Nappi G (2010) Focus on therapy of primary stabbing headache. J Headache Pain 11(2):157–160 (epub 2010 Jan 30; review)PubMedCentralPubMedCrossRef
3.
go back to reference Allena M, Rossi P, Tassorelli C, Ferrante E, Lisotto C, Nappi G (2010) Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity. J Headache Pain 11(6):525–530 (epub 2010 Oct 2; review)PubMedCentralPubMedCrossRef Allena M, Rossi P, Tassorelli C, Ferrante E, Lisotto C, Nappi G (2010) Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity. J Headache Pain 11(6):525–530 (epub 2010 Oct 2; review)PubMedCentralPubMedCrossRef
4.
go back to reference Lisotto C, Rossi P, Tassorelli C, Ferrante E, Nappi G (2010) Focus on therapy of hypnic headache. J Headache Pain 11(4):349–354 (epub 2010 Jun 29; review)PubMedCentralPubMedCrossRef Lisotto C, Rossi P, Tassorelli C, Ferrante E, Nappi G (2010) Focus on therapy of hypnic headache. J Headache Pain 11(4):349–354 (epub 2010 Jun 29; review)PubMedCentralPubMedCrossRef
5.
go back to reference Rossi P, Tassorelli C, Allena M, Ferrante E, Lisotto C, Nappi G (2010) Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain 11(3):259–265 (epub 2010 Feb 26; review. PubMed PMID: 20186563)PubMedCentralPubMedCrossRef Rossi P, Tassorelli C, Allena M, Ferrante E, Lisotto C, Nappi G (2010) Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain 11(3):259–265 (epub 2010 Feb 26; review. PubMed PMID: 20186563)PubMedCentralPubMedCrossRef
7.
go back to reference Lipton RB, Stewart WF, Stone AM, Láinez MJ, Sawyer JP, Disability in Strategies of Care Study Group (2000) Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: 4. A randomized trial. JAMA 284(20):2599–2605PubMedCrossRef Lipton RB, Stewart WF, Stone AM, Láinez MJ, Sawyer JP, Disability in Strategies of Care Study Group (2000) Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: 4. A randomized trial. JAMA 284(20):2599–2605PubMedCrossRef
8.
go back to reference Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668–1675PubMedCrossRef Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668–1675PubMedCrossRef
9.
go back to reference Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D (2007) Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache 47:1152–1168PubMedCrossRef Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D (2007) Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache 47:1152–1168PubMedCrossRef
10.
go back to reference Tfelt-Hansen P (1998) Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia 18(8):532–538PubMedCrossRef Tfelt-Hansen P (1998) Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia 18(8):532–538PubMedCrossRef
11.
go back to reference Derry CJ, Derry S, Moore RA (2012) Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2:CD008615PubMedCentralPubMed Derry CJ, Derry S, Moore RA (2012) Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2:CD008615PubMedCentralPubMed
12.
go back to reference Derry CJ, Derry S, Moore RA (2012) Sumatriptan (rectal route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2:CD009664 Derry CJ, Derry S, Moore RA (2012) Sumatriptan (rectal route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2:CD009664
13.
go back to reference Tfelt-Hansen P (2000) Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia 20(2):137PubMedCrossRef Tfelt-Hansen P (2000) Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia 20(2):137PubMedCrossRef
14.
go back to reference Chen LC, Ashcroft DM (2008) Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 48(2):236–247PubMedCrossRef Chen LC, Ashcroft DM (2008) Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 48(2):236–247PubMedCrossRef
15.
go back to reference Oldman AD, Smith LA, McQuay HJ, Moore RA (2001) Rizatriptan for acute migraine. Cochrane Database Syst Rev (3):CD003221 Oldman AD, Smith LA, McQuay HJ, Moore RA (2001) Rizatriptan for acute migraine. Cochrane Database Syst Rev (3):CD003221
16.
go back to reference Ferrari MD, Loder E, McCarroll KA, Lines CR (2001) Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia 21(2):129–136PubMedCrossRef Ferrari MD, Loder E, McCarroll KA, Lines CR (2001) Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia 21(2):129–136PubMedCrossRef
17.
go back to reference Mathew NT (2005) Efficacy and tolerability of almotriptan in controlled clinical trials. Eur Neurol 53(Suppl 1):29–33 (epub 2005 May 3; review)PubMedCrossRef Mathew NT (2005) Efficacy and tolerability of almotriptan in controlled clinical trials. Eur Neurol 53(Suppl 1):29–33 (epub 2005 May 3; review)PubMedCrossRef
18.
go back to reference Smith LA, Oldman AD, McQuay HJ, Moore RA (2001) Eletriptan for acute migraine. Cochrane Database Syst Rev (3):CD003224 Smith LA, Oldman AD, McQuay HJ, Moore RA (2001) Eletriptan for acute migraine. Cochrane Database Syst Rev (3):CD003224
19.
go back to reference Elkind AH, MacGregor EA (2008) Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine. Expert Rev Neurother 8(5):723–736PubMedCrossRef Elkind AH, MacGregor EA (2008) Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine. Expert Rev Neurother 8(5):723–736PubMedCrossRef
20.
go back to reference Göbel H, Heinze A, Stolze H, Heinze-Kuhn K, Lindner V (1999) Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Cephalalgia 19(7):676–683 (discussion 626)PubMedCrossRef Göbel H, Heinze A, Stolze H, Heinze-Kuhn K, Lindner V (1999) Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Cephalalgia 19(7):676–683 (discussion 626)PubMedCrossRef
21.
go back to reference Pringsheim T, Davenport WJ, Dodick D (2008) Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 70(17):1555–1563PubMedCrossRef Pringsheim T, Davenport WJ, Dodick D (2008) Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 70(17):1555–1563PubMedCrossRef
22.
go back to reference Mett A, Tfelt-Hansen P (2008) Acute migraine therapy: recent evidence from randomized comparative trials. Curr Opin Neurol 21(3):331–337PubMedCrossRef Mett A, Tfelt-Hansen P (2008) Acute migraine therapy: recent evidence from randomized comparative trials. Curr Opin Neurol 21(3):331–337PubMedCrossRef
23.
go back to reference Dowson AJ, Tepper SJ, Dahlöf C (2005) Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine. J Headache Pain 6(3):112–120 (epub 2005 May 13)PubMedCentralPubMedCrossRef Dowson AJ, Tepper SJ, Dahlöf C (2005) Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine. J Headache Pain 6(3):112–120 (epub 2005 May 13)PubMedCentralPubMedCrossRef
24.
go back to reference Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P (2004) Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clin Ther 26(9):1533–1545PubMedCrossRef Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P (2004) Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clin Ther 26(9):1533–1545PubMedCrossRef
25.
go back to reference Buzzi MG (2008) Pathways to the best fit of triptans for migraine patients. Cephalalgia 28(Suppl 2):21–27 Buzzi MG (2008) Pathways to the best fit of triptans for migraine patients. Cephalalgia 28(Suppl 2):21–27
26.
go back to reference Belvís R, Pagonabarraga J, Kulisevsky J (2008) Individual triptan selection in migraine attack therapy. Recent Pat CNS Drug Discov 4(1):70–81CrossRef Belvís R, Pagonabarraga J, Kulisevsky J (2008) Individual triptan selection in migraine attack therapy. Recent Pat CNS Drug Discov 4(1):70–81CrossRef
27.
go back to reference Blau JN (1992) Sumatriptan and recurrence of migraine. Lancet 340(8827):1110PubMed Blau JN (1992) Sumatriptan and recurrence of migraine. Lancet 340(8827):1110PubMed
28.
go back to reference Cortelli P, Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G (2011) Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurol Sci 32(Suppl 1):S95–S98PubMedCrossRef Cortelli P, Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G (2011) Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurol Sci 32(Suppl 1):S95–S98PubMedCrossRef
29.
go back to reference Láinez M (2004) Clinical benefits of early triptan therapy for migraine. Cephalalgia 24(Suppl 2):24–30 (review)PubMedCrossRef Láinez M (2004) Clinical benefits of early triptan therapy for migraine. Cephalalgia 24(Suppl 2):24–30 (review)PubMedCrossRef
30.
go back to reference Goadsby PJ (2008) The ‘Act when Mild’ (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia 28(Suppl 2):36–41 (review)PubMedCrossRef Goadsby PJ (2008) The ‘Act when Mild’ (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia 28(Suppl 2):36–41 (review)PubMedCrossRef
31.
go back to reference Valade D (2009) Early treatment of acute migraine: new evidence of benefits. Cephalalgia 29(Suppl 3):15–21PubMed Valade D (2009) Early treatment of acute migraine: new evidence of benefits. Cephalalgia 29(Suppl 3):15–21PubMed
32.
go back to reference Dodick DW (2005) Triptan nonresponder studies: implications for clinical practice. Headache 45(2):156–162PubMedCrossRef Dodick DW (2005) Triptan nonresponder studies: implications for clinical practice. Headache 45(2):156–162PubMedCrossRef
33.
go back to reference Färkkilä M, Olesen J, Dahlöf C, Stovner LJ, ter Bruggen JP, Rasmussen S, Muirhead N, Sikes C (2003) Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 23(6):463–471PubMedCrossRef Färkkilä M, Olesen J, Dahlöf C, Stovner LJ, ter Bruggen JP, Rasmussen S, Muirhead N, Sikes C (2003) Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 23(6):463–471PubMedCrossRef
34.
go back to reference Diener HC, Gendolla A, Gebert I, Beneke M (2005) Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Headache 45(7):874–882PubMedCrossRef Diener HC, Gendolla A, Gebert I, Beneke M (2005) Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Headache 45(7):874–882PubMedCrossRef
35.
go back to reference Diener HC (2005) Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Curr Med Res Opin 21(10):1603–1610PubMedCrossRef Diener HC (2005) Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Curr Med Res Opin 21(10):1603–1610PubMedCrossRef
36.
go back to reference Dahlöf CG (2006) Infrequent or non-response to oral sumatriptan does not predict response to other triptans—review of four trials. Cephalalgia 26(2):98–106 (review)PubMedCrossRef Dahlöf CG (2006) Infrequent or non-response to oral sumatriptan does not predict response to other triptans—review of four trials. Cephalalgia 26(2):98–106 (review)PubMedCrossRef
37.
go back to reference Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR (2006) Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Headache 46(7):1142–1150PubMedCrossRef Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR (2006) Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Headache 46(7):1142–1150PubMedCrossRef
38.
go back to reference Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R (2005) Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 45(7):850–861PubMedCrossRef Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R (2005) Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 45(7):850–861PubMedCrossRef
40.
go back to reference Cady R, Schreiber C (2006) Sumatriptan: update and review. Expert Opin Pharmacother 7(11):1503–1514PubMedCrossRef Cady R, Schreiber C (2006) Sumatriptan: update and review. Expert Opin Pharmacother 7(11):1503–1514PubMedCrossRef
41.
go back to reference Dahlöf C (1999) Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia 19(9):769–778PubMedCrossRef Dahlöf C (1999) Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia 19(9):769–778PubMedCrossRef
42.
go back to reference Ahrens SP, Farmer MV, Williams DL, Willoughby E, Jiang K, Block GA, Visser WH (1999) Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group. Cephalalgia 19(5):525–530PubMedCrossRef Ahrens SP, Farmer MV, Williams DL, Willoughby E, Jiang K, Block GA, Visser WH (1999) Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group. Cephalalgia 19(5):525–530PubMedCrossRef
43.
go back to reference Spierings EL, Rapoport AM, Dodick DW, Charlesworth B (2004) Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs 18(15):1133–1141PubMedCrossRef Spierings EL, Rapoport AM, Dodick DW, Charlesworth B (2004) Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs 18(15):1133–1141PubMedCrossRef
44.
go back to reference The Multinational Oral Sumatriptan and Cafergot Comparative Study Group (1991) A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 31(5):314–322 The Multinational Oral Sumatriptan and Cafergot Comparative Study Group (1991) A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 31(5):314–322
45.
go back to reference Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ, Eletriptan and Cafergot Comparative Study Group (2002) Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol 47(2):99–107PubMedCrossRef Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ, Eletriptan and Cafergot Comparative Study Group (2002) Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol 47(2):99–107PubMedCrossRef
46.
go back to reference Láinez MJ, Galván J, Heras J, Vila C (2007) Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. Eur J Neurol 14(3):269–275PubMedCrossRef Láinez MJ, Galván J, Heras J, Vila C (2007) Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. Eur J Neurol 14(3):269–275PubMedCrossRef
47.
go back to reference Christie S, Göbel H, Mateos V, Allen C, Vrijens F, Shivaprakash M, Rizatriptan-Ergotamine/Caffeine Preference Study Group (2003) Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Eur Neurol 49(1):20–29PubMedCrossRef Christie S, Göbel H, Mateos V, Allen C, Vrijens F, Shivaprakash M, Rizatriptan-Ergotamine/Caffeine Preference Study Group (2003) Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Eur Neurol 49(1):20–29PubMedCrossRef
48.
go back to reference Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71(22):1821–1828 (review)PubMedCrossRef Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71(22):1821–1828 (review)PubMedCrossRef
49.
go back to reference Cleves C, Tepper SJ (2008) Sumatriptan/naproxen sodium combination for the treatment of migraine. Expert Rev Neurother 8(9):1289–1297 (review)PubMedCrossRef Cleves C, Tepper SJ (2008) Sumatriptan/naproxen sodium combination for the treatment of migraine. Expert Rev Neurother 8(9):1289–1297 (review)PubMedCrossRef
50.
go back to reference Lipton RB, Dodick DW, Adelman JU, Kaniecki RG, Lener SE, White JD, Nelsen AC (2009) Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study. Cephalalgia 29(8):826–836 (epub 2009 Feb 12)PubMedCrossRef Lipton RB, Dodick DW, Adelman JU, Kaniecki RG, Lener SE, White JD, Nelsen AC (2009) Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study. Cephalalgia 29(8):826–836 (epub 2009 Feb 12)PubMedCrossRef
51.
go back to reference Krymchantowski AV, Bigal ME (2004) Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol 4:10PubMedCentralPubMedCrossRef Krymchantowski AV, Bigal ME (2004) Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol 4:10PubMedCentralPubMedCrossRef
52.
go back to reference Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F (2008) Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Headache 48(6):921–930PubMedCrossRef Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F (2008) Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Headache 48(6):921–930PubMedCrossRef
53.
go back to reference Whyte CA, Tepper SJ (2009) Adverse effects of medications commonly used in the treatment of migraine. Expert Rev Neurother 9(9):1379–1391 (review)PubMedCrossRef Whyte CA, Tepper SJ (2009) Adverse effects of medications commonly used in the treatment of migraine. Expert Rev Neurother 9(9):1379–1391 (review)PubMedCrossRef
54.
go back to reference Duong S, Bozzo P, Nordeng H, Einarson A (2010) Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can Fam Physician 56(6):537–539PubMedCentralPubMed Duong S, Bozzo P, Nordeng H, Einarson A (2010) Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can Fam Physician 56(6):537–539PubMedCentralPubMed
55.
go back to reference Callenbach PM, Pels LP, Mulder PG, Linssen WH, Gooskens RH, van der Zwan JL, Brouwer OF, SUM30042 Trial Group (2007) Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children. Eur J Paediatr Neurol 11(6):325–330 (epub 2007 Apr 10)PubMedCrossRef Callenbach PM, Pels LP, Mulder PG, Linssen WH, Gooskens RH, van der Zwan JL, Brouwer OF, SUM30042 Trial Group (2007) Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children. Eur J Paediatr Neurol 11(6):325–330 (epub 2007 Apr 10)PubMedCrossRef
56.
go back to reference Lewis DW, Winner P, Hershey AD, Wasiewski WW, Adolescent Migraine Steering Committee (2007) Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120(2):390–396PubMedCrossRef Lewis DW, Winner P, Hershey AD, Wasiewski WW, Adolescent Migraine Steering Committee (2007) Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120(2):390–396PubMedCrossRef
58.
go back to reference Eadie MJ (2001) Clinically significant drug interactions with agents specific for migraine attacks. CNS Drugs 15(2):105–118PubMedCrossRef Eadie MJ (2001) Clinically significant drug interactions with agents specific for migraine attacks. CNS Drugs 15(2):105–118PubMedCrossRef
59.
go back to reference Pfaffenrath V, Scherzer S (1995) Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia 15(Suppl 15):14–20 (review)PubMed Pfaffenrath V, Scherzer S (1995) Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia 15(Suppl 15):14–20 (review)PubMed
60.
go back to reference Limmroth V (2001) Analgesics. Curr Med Res Opin 17(Suppl 1):s13–s16 (review)PubMed Limmroth V (2001) Analgesics. Curr Med Res Opin 17(Suppl 1):s13–s16 (review)PubMed
61.
go back to reference Derry S, Moore RA, McQuay HJ (2010) Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 11:CD008040PubMed Derry S, Moore RA, McQuay HJ (2010) Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 11:CD008040PubMed
62.
go back to reference Kirthi V, Derry S, Moore RA, McQuay HJ (2010) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD008041 (review)PubMed Kirthi V, Derry S, Moore RA, McQuay HJ (2010) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD008041 (review)PubMed
63.
go back to reference Rabbie R, Derry S, Moore RA, McQuay HJ (2010) Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 10:CD008039PubMed Rabbie R, Derry S, Moore RA, McQuay HJ (2010) Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 10:CD008039PubMed
64.
go back to reference Derry S, Rabbie R, Moore RA (2012) Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2:CD008783PubMedCentralPubMed Derry S, Rabbie R, Moore RA (2012) Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2:CD008783PubMedCentralPubMed
65.
go back to reference Suthisisang CC, Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukgid B (2010) Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache 50(5):808–818 (epub 2010 Mar 5)PubMedCrossRef Suthisisang CC, Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukgid B (2010) Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache 50(5):808–818 (epub 2010 Mar 5)PubMedCrossRef
66.
go back to reference Shrestha M, Singh R, Moreden J, Hayes JE (1996) Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med 156(15):1725–1728PubMedCrossRef Shrestha M, Singh R, Moreden J, Hayes JE (1996) Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med 156(15):1725–1728PubMedCrossRef
67.
go back to reference Seim MB, March JA, Dunn KA (1998) Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med 5(6):573–576PubMedCrossRef Seim MB, March JA, Dunn KA (1998) Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med 5(6):573–576PubMedCrossRef
68.
go back to reference Meredith JT, Wait S, Brewer KL (2003) A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med 21(3):173–175PubMedCrossRef Meredith JT, Wait S, Brewer KL (2003) A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med 21(3):173–175PubMedCrossRef
69.
go back to reference Tfelt-Hansen PC, Koehler PJ (2008) History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia 28(8):877–886 (epub 2008 May 5)PubMedCrossRef Tfelt-Hansen PC, Koehler PJ (2008) History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia 28(8):877–886 (epub 2008 May 5)PubMedCrossRef
70.
go back to reference Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9–18 (review)PubMedCrossRef Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9–18 (review)PubMedCrossRef
71.
go back to reference Saper JR, Silberstein S (2006) Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache 46(Suppl 4):S171–S181PubMedCrossRef Saper JR, Silberstein S (2006) Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache 46(Suppl 4):S171–S181PubMedCrossRef
72.
go back to reference Azzopardi TD, Brooks NA (2008) Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine. Ann Pharmacother 42(3):397–402 (epub 2008 Feb 19)PubMedCrossRef Azzopardi TD, Brooks NA (2008) Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine. Ann Pharmacother 42(3):397–402 (epub 2008 Feb 19)PubMedCrossRef
73.
go back to reference Lipton RB (1997) Ergotamine tartrate and dihydroergotamine mesylate: safety profiles. Headache 37(Suppl 1):S33–S41PubMed Lipton RB (1997) Ergotamine tartrate and dihydroergotamine mesylate: safety profiles. Headache 37(Suppl 1):S33–S41PubMed
76.
go back to reference Anneken K, Evers S, Husstedt IW (2010) Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review. Eur J Neurol 17(4):534-e25 (review) Anneken K, Evers S, Husstedt IW (2010) Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review. Eur J Neurol 17(4):534-e25 (review)
77.
go back to reference Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C, Vecchiet L, Sicuteri F (2003) Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache 43(8):835–844PubMedCrossRef Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C, Vecchiet L, Sicuteri F (2003) Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache 43(8):835–844PubMedCrossRef
78.
go back to reference Sandrini G, Cerbo R, Del Bene E, Ferrari A, Genco S, Grazioli I, Martelletti P, Nappi G, Pinessi L, Sarchielli P, Tamburro P, Uslenghi C, Zanchin G (2007) Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Int J Clin Pract 61(8):1256–1269PubMedCentralPubMedCrossRef Sandrini G, Cerbo R, Del Bene E, Ferrari A, Genco S, Grazioli I, Martelletti P, Nappi G, Pinessi L, Sarchielli P, Tamburro P, Uslenghi C, Zanchin G (2007) Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Int J Clin Pract 61(8):1256–1269PubMedCentralPubMedCrossRef
79.
go back to reference Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(8):1157–1168PubMedCrossRef Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(8):1157–1168PubMedCrossRef
80.
go back to reference Feinstein AR, Heinemann LA, Dalessio D, Fox JM, Goldstein J, Haag G, Ladewig D, O’Brien CP (2000) Do caffeine-containing analgesics promote dependence? A review and evaluation. Clin Pharmacol Ther 68(5):457–467PubMedCrossRef Feinstein AR, Heinemann LA, Dalessio D, Fox JM, Goldstein J, Haag G, Ladewig D, O’Brien CP (2000) Do caffeine-containing analgesics promote dependence? A review and evaluation. Clin Pharmacol Ther 68(5):457–467PubMedCrossRef
81.
go back to reference Ferrari A, Savino G, Gallesi D, Pinetti D, Bertolini A, Sances G, Coccia CP, Pasciullo G, Leone S, Loi M, Sternieri E (2006) Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients. Pharmacol Res 54(2):142–149 (epub 2006 Apr 7)PubMedCrossRef Ferrari A, Savino G, Gallesi D, Pinetti D, Bertolini A, Sances G, Coccia CP, Pasciullo G, Leone S, Loi M, Sternieri E (2006) Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients. Pharmacol Res 54(2):142–149 (epub 2006 Apr 7)PubMedCrossRef
82.
go back to reference Becker WL (1999) Migraine-associated symptoms: clinical significance and management. Can J Clin Pharmacol 6(Suppl A):15A–19A (review)PubMed Becker WL (1999) Migraine-associated symptoms: clinical significance and management. Can J Clin Pharmacol 6(Suppl A):15A–19A (review)PubMed
83.
go back to reference Schulman EA, Dermott KF (2003) Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 43(7):729–733PubMedCrossRef Schulman EA, Dermott KF (2003) Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 43(7):729–733PubMedCrossRef
84.
go back to reference Schwarzberg MN (1994) Application of metoclopramide specificity in migraine attacks therapy. Headache 34(7):439–441PubMedCrossRef Schwarzberg MN (1994) Application of metoclopramide specificity in migraine attacks therapy. Headache 34(7):439–441PubMedCrossRef
85.
go back to reference Kelly AM, Walcynski T, Gunn B (2009) The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis. Headache 49(9):1324–1332 (epub 2009 Jun 2)PubMedCrossRef Kelly AM, Walcynski T, Gunn B (2009) The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis. Headache 49(9):1324–1332 (epub 2009 Jun 2)PubMedCrossRef
86.
go back to reference Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH (2004) Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 329(7479):1369–1373 (epub 2004 Nov 18)PubMedCentralPubMedCrossRef Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH (2004) Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 329(7479):1369–1373 (epub 2004 Nov 18)PubMedCentralPubMedCrossRef
87.
go back to reference Waelkens J (1984) Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 4(2):85–90PubMedCrossRef Waelkens J (1984) Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 4(2):85–90PubMedCrossRef
88.
go back to reference Waelkens J (1982) Domperidone in the prevention of complete classical migraine. Br Med J (Clin Res Ed) 284(6320):944CrossRef Waelkens J (1982) Domperidone in the prevention of complete classical migraine. Br Med J (Clin Res Ed) 284(6320):944CrossRef
89.
go back to reference Gill SK, Einarson A (2007) The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf 6(6):685–694PubMedCrossRef Gill SK, Einarson A (2007) The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf 6(6):685–694PubMedCrossRef
90.
go back to reference Somerville BW (1976) Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust 1(23):865–866PubMed Somerville BW (1976) Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust 1(23):865–866PubMed
91.
go back to reference Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuillerie G (1994) Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia 14(2):156–161PubMedCrossRef Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuillerie G (1994) Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia 14(2):156–161PubMedCrossRef
92.
go back to reference Hakkarainen H, Gustafsson B, Stockman O (1978) A comparative trail of ergotamine tartrate, acetyl salicylic acid and a dextropropoxyphene compound in acute migraine attacks. Headache 18(1):35–39 (no abstract available)PubMedCrossRef Hakkarainen H, Gustafsson B, Stockman O (1978) A comparative trail of ergotamine tartrate, acetyl salicylic acid and a dextropropoxyphene compound in acute migraine attacks. Headache 18(1):35–39 (no abstract available)PubMedCrossRef
93.
go back to reference Melanson SW, Morse JW, Pronchik DJ, Heller MB (1997) Transnasal butorphanol in the emergency department management of migraine headache. Am J Emerg Med 15(1):57–61PubMedCrossRef Melanson SW, Morse JW, Pronchik DJ, Heller MB (1997) Transnasal butorphanol in the emergency department management of migraine headache. Am J Emerg Med 15(1):57–61PubMedCrossRef
94.
go back to reference Hoffert MJ, Couch JR, Diamond S, Elkind AH, Goldstein J, Kohlerman NJ 3rd, Saper JR, Solomon S (1995) Transnasal butorphanol in the treatment of acute migraine. Headache 35(2):65–69PubMedCrossRef Hoffert MJ, Couch JR, Diamond S, Elkind AH, Goldstein J, Kohlerman NJ 3rd, Saper JR, Solomon S (1995) Transnasal butorphanol in the treatment of acute migraine. Headache 35(2):65–69PubMedCrossRef
95.
go back to reference Davis CP, Torre PR, Williams C, Gray C, Barrett K, Krucke G, Peake D, Bass B Jr (1995) Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients. Am J Emerg Med 13(2):146–150PubMedCrossRef Davis CP, Torre PR, Williams C, Gray C, Barrett K, Krucke G, Peake D, Bass B Jr (1995) Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients. Am J Emerg Med 13(2):146–150PubMedCrossRef
96.
go back to reference Silberstein SD, Freitag FG, Rozen TD, Kudrow DB, Hewitt DJ, Jordan DM, Fisher AC, Rosenthal NR, CAPSS-223 Investigators (2005) Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Headache 45(10):1317–1327PubMedCrossRef Silberstein SD, Freitag FG, Rozen TD, Kudrow DB, Hewitt DJ, Jordan DM, Fisher AC, Rosenthal NR, CAPSS-223 Investigators (2005) Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Headache 45(10):1317–1327PubMedCrossRef
97.
go back to reference Engindeniz Z, Demircan C, Karli N, Armagan E, Bulut M, Aydin T, Zarifoglu M (2005) Intramuscular tramadol vs. diclofenac sodium for the treatment of acute migraine attacks in emergency department: a prospective, randomised, double-blind study. J Headache Pain 6(3):143–148 (epub 2005 May 13)PubMedCentralPubMedCrossRef Engindeniz Z, Demircan C, Karli N, Armagan E, Bulut M, Aydin T, Zarifoglu M (2005) Intramuscular tramadol vs. diclofenac sodium for the treatment of acute migraine attacks in emergency department: a prospective, randomised, double-blind study. J Headache Pain 6(3):143–148 (epub 2005 May 13)PubMedCentralPubMedCrossRef
98.
go back to reference Alemdar M, Pekdemir M, Selekler HM (2007) Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial. Clin Ther 29(7):1441–1447PubMedCrossRef Alemdar M, Pekdemir M, Selekler HM (2007) Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial. Clin Ther 29(7):1441–1447PubMedCrossRef
99.
go back to reference Bigal ME, Lipton RB (2009) Excessive opioid use and the development of chronic migraine. Pain 142(3):179–182 (epub 2009 Feb 15)PubMedCrossRef Bigal ME, Lipton RB (2009) Excessive opioid use and the development of chronic migraine. Pain 142(3):179–182 (epub 2009 Feb 15)PubMedCrossRef
100.
go back to reference Silberstein SD, McCrory DC (2001) Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache 41(10):953–967PubMedCrossRef Silberstein SD, McCrory DC (2001) Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache 41(10):953–967PubMedCrossRef
101.
go back to reference Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD (2004) Intranasal medications for the treatment of migraine and cluster headache. CNS Drugs 18(10):671–685 (review)PubMedCrossRef Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD (2004) Intranasal medications for the treatment of migraine and cluster headache. CNS Drugs 18(10):671–685 (review)PubMedCrossRef
102.
go back to reference Maizels M, Scott B, Cohen W, Chen W (1996) Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 276(4):319–321PubMedCrossRef Maizels M, Scott B, Cohen W, Chen W (1996) Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 276(4):319–321PubMedCrossRef
103.
go back to reference Blanda M, Rench T, Gerson LW, Weigand JV (2001) Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial. Acad Emerg Med 8(4):337–342PubMedCrossRef Blanda M, Rench T, Gerson LW, Weigand JV (2001) Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial. Acad Emerg Med 8(4):337–342PubMedCrossRef
104.
go back to reference Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH (2008) Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 336(7657):1359–1361 (epub 2008 Jun 9; review)PubMedCentralPubMedCrossRef Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH (2008) Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 336(7657):1359–1361 (epub 2008 Jun 9; review)PubMedCentralPubMedCrossRef
105.
go back to reference Singh A, Alter HJ, Zaia B (2008) Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 15(12):1223–1233 (epub 2008 Oct 25; review. Erratum in: Acad Emerg Med. 2009 May;16(5):435)PubMedCrossRef Singh A, Alter HJ, Zaia B (2008) Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 15(12):1223–1233 (epub 2008 Oct 25; review. Erratum in: Acad Emerg Med. 2009 May;16(5):435)PubMedCrossRef
106.
go back to reference Fiesseler FW, Shih R, Szucs P, Silverman ME, Eskin B, Clement M, Saxena R, Allegra J, Riggs RL, Majlesi N (2011) Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial. J Emerg Med 40(4):463–468 Fiesseler FW, Shih R, Szucs P, Silverman ME, Eskin B, Clement M, Saxena R, Allegra J, Riggs RL, Majlesi N (2011) Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial. J Emerg Med 40(4):463–468
107.
go back to reference Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, Corbo J, Chu J, Chew E, Cheung P, Fearon S, Paternoster J, Baccellieri A, Clark S, Bijur PE, Lipton RB, Gallagher EJ (2007) Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology 69(22):2038–2044 (epub 2007 Oct 17)PubMedCrossRef Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, Corbo J, Chu J, Chew E, Cheung P, Fearon S, Paternoster J, Baccellieri A, Clark S, Bijur PE, Lipton RB, Gallagher EJ (2007) Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology 69(22):2038–2044 (epub 2007 Oct 17)PubMedCrossRef
108.
go back to reference Kelly AM, Kerr D, Clooney M (2008) Impact of oral dexamethasone versus placebo after ED treatment of migraine with phenothiazines on the rate of recurrent headache: a randomised controlled trial. Emerg Med J 25(1):26–29PubMedCrossRef Kelly AM, Kerr D, Clooney M (2008) Impact of oral dexamethasone versus placebo after ED treatment of migraine with phenothiazines on the rate of recurrent headache: a randomised controlled trial. Emerg Med J 25(1):26–29PubMedCrossRef
109.
go back to reference Prakash S, Shah ND (2009) Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache 49(8):1235–1239 (epub 2009 Jun 22)PubMedCrossRef Prakash S, Shah ND (2009) Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache 49(8):1235–1239 (epub 2009 Jun 22)PubMedCrossRef
110.
go back to reference Robbins MS, Wang D, DeOrchis VS (2010) Methylprednisolone for status migrainous vertigo and cephalic status migrainosus. Headache 50(2):328PubMedCrossRef Robbins MS, Wang D, DeOrchis VS (2010) Methylprednisolone for status migrainous vertigo and cephalic status migrainosus. Headache 50(2):328PubMedCrossRef
111.
go back to reference Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A (2008) A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 48(9):1286–1293PubMedCrossRef Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A (2008) A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 48(9):1286–1293PubMedCrossRef
112.
go back to reference Frazee LA, Foraker KC (2008) Use of intravenous valproic acid for acute migraine. Ann Pharmacother 42(3):403–407 (epub 2008 Feb 26)PubMedCrossRef Frazee LA, Foraker KC (2008) Use of intravenous valproic acid for acute migraine. Ann Pharmacother 42(3):403–407 (epub 2008 Feb 26)PubMedCrossRef
113.
go back to reference Hoffmann J, Goadsby PJ (2012) New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol 14(1):50–59PubMedCrossRef Hoffmann J, Goadsby PJ (2012) New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol 14(1):50–59PubMedCrossRef
114.
116.
go back to reference Limmroth V, Michel MC (2001) The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol 52(3):237–243PubMedCentralPubMedCrossRef Limmroth V, Michel MC (2001) The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol 52(3):237–243PubMedCentralPubMedCrossRef
117.
118.
go back to reference Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev (2):CD003225 (review) Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev (2):CD003225 (review)
119.
go back to reference Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K (2008) Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment? Headache 48(1):118–125PubMed Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K (2008) Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment? Headache 48(1):118–125PubMed
120.
go back to reference Johannsson V, Nilsson LR, Widelius T, Jäverfalk T, Hellman P, Akesson JA, Olerud B, Gustafsson CL, Raak A, Sandahl G et al (1987) Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 27(7):372–374PubMedCrossRef Johannsson V, Nilsson LR, Widelius T, Jäverfalk T, Hellman P, Akesson JA, Olerud B, Gustafsson CL, Raak A, Sandahl G et al (1987) Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 27(7):372–374PubMedCrossRef
121.
go back to reference Forssman B, Lindblad CJ, Zbornikova V (1983) Atenolol for migraine prophylaxis. Headache 23(4):188–190PubMedCrossRef Forssman B, Lindblad CJ, Zbornikova V (1983) Atenolol for migraine prophylaxis. Headache 23(4):188–190PubMedCrossRef
122.
go back to reference Ryan RE Sr, Ryan RE Jr, Sudilovsky A (1982) Nadolol and placebo comparison study in the prophylactic treatment of migraine. Panminerva Med 24(2):89–94PubMed Ryan RE Sr, Ryan RE Jr, Sudilovsky A (1982) Nadolol and placebo comparison study in the prophylactic treatment of migraine. Panminerva Med 24(2):89–94PubMed
123.
go back to reference Freitag FG, Diamond S (1984) Nadolol and placebo comparison study in the prophylactic treatment of migraine. J Am Osteopath Assoc 84(4):343–347PubMed Freitag FG, Diamond S (1984) Nadolol and placebo comparison study in the prophylactic treatment of migraine. J Am Osteopath Assoc 84(4):343–347PubMed
124.
go back to reference van de Ven LL, Franke CL, Koehler PJ (1997) Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 17(5):596–599PubMedCrossRef van de Ven LL, Franke CL, Koehler PJ (1997) Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 17(5):596–599PubMedCrossRef
125.
go back to reference Pfaffenrath V, Rehm M (1998) Migraine in pregnancy: what are the safest treatment options? Drug Saf 19(5):383–388PubMedCrossRef Pfaffenrath V, Rehm M (1998) Migraine in pregnancy: what are the safest treatment options? Drug Saf 19(5):383–388PubMedCrossRef
126.
go back to reference Ludin HP (1991) The place of calcium antagonists in the prophylactic treatment of migraine. J Cardiovasc Pharmacol 18(Suppl 8):S17–S19 (review)PubMedCrossRef Ludin HP (1991) The place of calcium antagonists in the prophylactic treatment of migraine. J Cardiovasc Pharmacol 18(Suppl 8):S17–S19 (review)PubMedCrossRef
127.
go back to reference Centonze V, Magrone D, Vino M, Caporaletti P, Attolini E, Campanale G, Albano O (1990) Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels. Cephalalgia 10(1):17–24PubMedCrossRef Centonze V, Magrone D, Vino M, Caporaletti P, Attolini E, Campanale G, Albano O (1990) Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels. Cephalalgia 10(1):17–24PubMedCrossRef
128.
go back to reference Diener HC, Matias-Guiu J, Hartung E, Pfaffenrath V, Ludin HP, Nappi G, De Beukelaar F (2002) Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia 22(3):209–221 (erratum in: Cephalalgia. 2002 Jul;22(6):488)PubMedCrossRef Diener HC, Matias-Guiu J, Hartung E, Pfaffenrath V, Ludin HP, Nappi G, De Beukelaar F (2002) Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia 22(3):209–221 (erratum in: Cephalalgia. 2002 Jul;22(6):488)PubMedCrossRef
129.
go back to reference Togha M, Ashrafian H, Tajik P (2006) Open-label trial of cinnarizine in migraine prophylaxis. Headache 46(3):498–502PubMedCrossRef Togha M, Ashrafian H, Tajik P (2006) Open-label trial of cinnarizine in migraine prophylaxis. Headache 46(3):498–502PubMedCrossRef
130.
go back to reference Togha M, Rahmat Jirde M, Nilavari K, Ashrafian H, Razeghi S, Kohan L (2008) Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 9(2):77–82 (epub 2008 Feb 20. Erratum in: J Headache Pain. 2008 Aug;9(4):257)PubMedCrossRef Togha M, Rahmat Jirde M, Nilavari K, Ashrafian H, Razeghi S, Kohan L (2008) Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 9(2):77–82 (epub 2008 Feb 20. Erratum in: J Headache Pain. 2008 Aug;9(4):257)PubMedCrossRef
131.
go back to reference Krebs R (1983) Adverse reactions with calcium antagonists. Hypertension 5(4 Pt 2):II125–II129PubMed Krebs R (1983) Adverse reactions with calcium antagonists. Hypertension 5(4 Pt 2):II125–II129PubMed
132.
go back to reference Daniel JR, Mauro VF (1995) Extrapyramidal symptoms associated with calcium-channel blockers. Ann Pharmacother 29(1):73–75 (review)PubMed Daniel JR, Mauro VF (1995) Extrapyramidal symptoms associated with calcium-channel blockers. Ann Pharmacother 29(1):73–75 (review)PubMed
133.
go back to reference Punay NC, Couch JR (2003) Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 7(1):51–54PubMedCrossRef Punay NC, Couch JR (2003) Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 7(1):51–54PubMedCrossRef
136.
go back to reference Bulut S, Berilgen MS, Baran A, Tekatas A, Atmaca M, Mungen B (2004) Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 107(1):44–48PubMedCrossRef Bulut S, Berilgen MS, Baran A, Tekatas A, Atmaca M, Mungen B (2004) Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 107(1):44–48PubMedCrossRef
137.
go back to reference Tarlaci S (2009) Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol 32(5):254–258PubMedCrossRef Tarlaci S (2009) Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol 32(5):254–258PubMedCrossRef
138.
go back to reference Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R (2005) The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 45(2):144–152PubMedCrossRef Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R (2005) The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 45(2):144–152PubMedCrossRef
139.
go back to reference Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 20(3):CD002919 (review) Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 20(3):CD002919 (review)
141.
go back to reference Park HJ, Lee ST, Shim JY, Kim B, Hwang SH, Kim SH, Park JE, Park JH, Jung SH, Ahn JY, Chu K, Kim M (2006) The effect of paroxetine on the reduction of migraine frequency is independent of its anxiolytic effect. J Clin Neurol 2(4):246–251 (epub 2006 Dec 20)PubMedCentralPubMedCrossRef Park HJ, Lee ST, Shim JY, Kim B, Hwang SH, Kim SH, Park JE, Park JH, Jung SH, Ahn JY, Chu K, Kim M (2006) The effect of paroxetine on the reduction of migraine frequency is independent of its anxiolytic effect. J Clin Neurol 2(4):246–251 (epub 2006 Dec 20)PubMedCentralPubMedCrossRef
142.
go back to reference Bánk J (1994) A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 34(8):476–478PubMedCrossRef Bánk J (1994) A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 34(8):476–478PubMedCrossRef
143.
go back to reference Munera PA, Goldstein A (2001) Migraine and sertraline. J Am Acad Child Adolesc Psychiatry 40(10):1125–1126PubMedCrossRef Munera PA, Goldstein A (2001) Migraine and sertraline. J Am Acad Child Adolesc Psychiatry 40(10):1125–1126PubMedCrossRef
144.
go back to reference Steiner TJ, Ahmed F, Findley LJ, MacGregor EA, Wilkinson M (1998) S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia 18(5):283–286PubMedCrossRef Steiner TJ, Ahmed F, Findley LJ, MacGregor EA, Wilkinson M (1998) S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia 18(5):283–286PubMedCrossRef
145.
go back to reference d’Amato CC, Pizza V, Marmolo T, Giordano E, Alfano V, Nasta A (1999) Fluoxetine for migraine prophylaxis: a double-blind trial. Headache 39(10):716–719PubMedCrossRef d’Amato CC, Pizza V, Marmolo T, Giordano E, Alfano V, Nasta A (1999) Fluoxetine for migraine prophylaxis: a double-blind trial. Headache 39(10):716–719PubMedCrossRef
146.
go back to reference Mulleners WM, Chronicle EP (2008) Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia 28(6):585–597 (review)PubMedCrossRef Mulleners WM, Chronicle EP (2008) Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia 28(6):585–597 (review)PubMedCrossRef
148.
go back to reference Lovell BV, Marmura MJ (2010) Valproate semisodium ER for migraine and cluster headache prophylaxis. Expert Opin Drug Metab Toxicol 6(4):495–504PubMedCrossRef Lovell BV, Marmura MJ (2010) Valproate semisodium ER for migraine and cluster headache prophylaxis. Expert Opin Drug Metab Toxicol 6(4):495–504PubMedCrossRef
149.
go back to reference Rothrock JF (1997) Successful treatment of persistent migraine aura with divalproex sodium. Neurology 48(1):261–262PubMedCrossRef Rothrock JF (1997) Successful treatment of persistent migraine aura with divalproex sodium. Neurology 48(1):261–262PubMedCrossRef
150.
go back to reference Erdemoglu AK, Ozbakir S (2000) Valproic acid in prophylaxis of refractory migraine. Acta Neurol Scand 102(6):354–358PubMedCrossRef Erdemoglu AK, Ozbakir S (2000) Valproic acid in prophylaxis of refractory migraine. Acta Neurol Scand 102(6):354–358PubMedCrossRef
151.
go back to reference Silberstein SD, Collins SD (1999) Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache 39(9):633–643PubMedCrossRef Silberstein SD, Collins SD (1999) Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache 39(9):633–643PubMedCrossRef
152.
go back to reference Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J (2003) Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr 8(6):428–432PubMed Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J (2003) Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr 8(6):428–432PubMed
153.
go back to reference Bussone G, Diener HC, Pfeil J, Schwalen S (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59(8):961–968PubMedCrossRef Bussone G, Diener HC, Pfeil J, Schwalen S (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59(8):961–968PubMedCrossRef
154.
go back to reference Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41(2):119–128PubMedCrossRef Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41(2):119–128PubMedCrossRef
155.
go back to reference D’Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 19(1):64–66PubMedCrossRef D’Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 19(1):64–66PubMedCrossRef
156.
go back to reference Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura–a pilot study. Cephalalgia 19(1):58–63PubMedCrossRef Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura–a pilot study. Cephalalgia 19(1):58–63PubMedCrossRef
157.
go back to reference Pascual J, Caminero AB, Mateos V, Roig C, Leira R, García-Moncó C, Laínez MJ (2004) Preventing disturbing migraine aura with lamotrigine: an open study. Headache 44(10):1024–1028PubMedCrossRef Pascual J, Caminero AB, Mateos V, Roig C, Leira R, García-Moncó C, Laínez MJ (2004) Preventing disturbing migraine aura with lamotrigine: an open study. Headache 44(10):1024–1028PubMedCrossRef
158.
go back to reference Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17(2):109–112PubMedCrossRef Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17(2):109–112PubMedCrossRef
159.
go back to reference Tomson T, Battino D (2005) Teratogenicity of antiepileptic drugs: state of the art. Curr Opin Neurol 18(2):135–140 (review)PubMedCrossRef Tomson T, Battino D (2005) Teratogenicity of antiepileptic drugs: state of the art. Curr Opin Neurol 18(2):135–140 (review)PubMedCrossRef
160.
go back to reference Perucca E, Meador KJ (2005) Adverse effects of antiepileptic drugs. Acta Neurol Scand Suppl 181:30–35PubMedCrossRef Perucca E, Meador KJ (2005) Adverse effects of antiepileptic drugs. Acta Neurol Scand Suppl 181:30–35PubMedCrossRef
161.
go back to reference Mylecharane EJ (1991) 5-HT2 receptor antagonists and migraine therapy. J Neurol 238(Suppl 1):S45–S52 (review)PubMedCrossRef Mylecharane EJ (1991) 5-HT2 receptor antagonists and migraine therapy. J Neurol 238(Suppl 1):S45–S52 (review)PubMedCrossRef
162.
go back to reference Behan PO, Connelly K (1986) Prophylaxis of migraine: a comparison between naproxen sodium and pizotifen. Headache 26(5):237–239PubMedCrossRef Behan PO, Connelly K (1986) Prophylaxis of migraine: a comparison between naproxen sodium and pizotifen. Headache 26(5):237–239PubMedCrossRef
163.
go back to reference Vilming S, Standnes B, Hedman C (1985) Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation. Cephalalgia 5(1):17–23PubMedCrossRef Vilming S, Standnes B, Hedman C (1985) Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation. Cephalalgia 5(1):17–23PubMedCrossRef
164.
go back to reference Cerbo R, Casacchia M, Formisano R, Feliciani M, Cusimano G, Buzzi MG, Agnoli A (1986) Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cephalalgia 6(1):15–18PubMedCrossRef Cerbo R, Casacchia M, Formisano R, Feliciani M, Cusimano G, Buzzi MG, Agnoli A (1986) Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cephalalgia 6(1):15–18PubMedCrossRef
165.
go back to reference Rascol A, Montastruc JL, Rascol O (1986) Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine. Headache 26(2):83–85PubMedCrossRef Rascol A, Montastruc JL, Rascol O (1986) Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine. Headache 26(2):83–85PubMedCrossRef
166.
go back to reference Young WB, Rozen TD (2005) Preventive treatment of migraine: effect on weight. Cephalalgia 25(1):1–11PubMedCrossRef Young WB, Rozen TD (2005) Preventive treatment of migraine: effect on weight. Cephalalgia 25(1):1–11PubMedCrossRef
167.
go back to reference Gales BJ, Bailey EK, Reed AN, Gales MA (2010) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines. Ann Pharmacother 44(2):360–366 (epub 2010 Jan 19; review)PubMedCrossRef Gales BJ, Bailey EK, Reed AN, Gales MA (2010) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines. Ann Pharmacother 44(2):360–366 (epub 2010 Jan 19; review)PubMedCrossRef
168.
go back to reference Stovner LJ (2007) Migraine prophylaxis with drugs influencing the renin-angiotensin system. Eur J Neurol 14(7):713–714PubMedCrossRef Stovner LJ (2007) Migraine prophylaxis with drugs influencing the renin-angiotensin system. Eur J Neurol 14(7):713–714PubMedCrossRef
169.
go back to reference Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G (2007) Efficacy of lisinopril in migraine prophylaxis—an open label study. Eur J Neurol 14(6):701–703PubMedCrossRef Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G (2007) Efficacy of lisinopril in migraine prophylaxis—an open label study. Eur J Neurol 14(6):701–703PubMedCrossRef
170.
go back to reference Schrader H, Stovner LJ, Helde G, Sand T, Bovim G (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 322(7277):19–22PubMedCentralPubMedCrossRef Schrader H, Stovner LJ, Helde G, Sand T, Bovim G (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 322(7277):19–22PubMedCentralPubMedCrossRef
171.
go back to reference Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289(1):65–69PubMedCrossRef Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289(1):65–69PubMedCrossRef
172.
go back to reference Pradalier A, Lantéri-Minet M, Géraud G, Allain H, Lucas C, Delgado A (2004) The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. CNS Drugs 18(15):1149–1163PubMedCrossRef Pradalier A, Lantéri-Minet M, Géraud G, Allain H, Lucas C, Delgado A (2004) The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. CNS Drugs 18(15):1149–1163PubMedCrossRef
173.
go back to reference Schürks M (2009) Dihydroergotamine: role in the treatment of migraine. Expert Opin Drug Metab Toxicol 5(9):1141–1148 (review)PubMedCrossRef Schürks M (2009) Dihydroergotamine: role in the treatment of migraine. Expert Opin Drug Metab Toxicol 5(9):1141–1148 (review)PubMedCrossRef
174.
go back to reference Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50(2):466–470PubMedCrossRef Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50(2):466–470PubMedCrossRef
175.
go back to reference Agosti R, Duke RK, Chrubasik JE, Chrubasik S (2006) Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine 13(9–10):743–746 (epub 2006 Sep 20)PubMedCrossRef Agosti R, Duke RK, Chrubasik JE, Chrubasik S (2006) Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine 13(9–10):743–746 (epub 2006 Sep 20)PubMedCrossRef
176.
go back to reference Pittler MH, Ernst E (2000) Feverfew for preventing migraine. Cochrane Database Syst Rev 2004(1):CD002286 (update of: Cochrane Database Syst Rev (3):CD002286) Pittler MH, Ernst E (2000) Feverfew for preventing migraine. Cochrane Database Syst Rev 2004(1):CD002286 (update of: Cochrane Database Syst Rev (3):CD002286)
177.
go back to reference Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64(4):713–715PubMedCrossRef Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64(4):713–715PubMedCrossRef
178.
go back to reference Magis D, Ambrosini A, Sándor P, Jacquy J, Laloux P, Schoenen J (2007) A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 47(1):52–57PubMedCrossRef Magis D, Ambrosini A, Sándor P, Jacquy J, Laloux P, Schoenen J (2007) A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 47(1):52–57PubMedCrossRef
179.
go back to reference Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H, Fischer M (1996) Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 16(6):436–440PubMedCrossRef Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H, Fischer M (1996) Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 16(6):436–440PubMedCrossRef
180.
go back to reference Peikert A, Wilimzig C, Köhne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16(4):257–263PubMedCrossRef Peikert A, Wilimzig C, Köhne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16(4):257–263PubMedCrossRef
181.
go back to reference Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR (2009) Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy 29(7):784–791PubMedCrossRef Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR (2009) Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy 29(7):784–791PubMedCrossRef
182.
go back to reference Sullivan E, Bushnell C (2010) Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep 14(5):376–384PubMedCentralPubMedCrossRef Sullivan E, Bushnell C (2010) Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep 14(5):376–384PubMedCentralPubMedCrossRef
183.
go back to reference MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S (2009) Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache 49(9):1298–1314PubMedCrossRef MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S (2009) Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache 49(9):1298–1314PubMedCrossRef
184.
go back to reference Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC (2009) Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation. Headache 49(9):1283–1297 (epub 2009 Sep 14)PubMedCrossRef Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC (2009) Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation. Headache 49(9):1283–1297 (epub 2009 Sep 14)PubMedCrossRef
185.
go back to reference Tuchman MM, Hee A, Emeribe U, Silberstein S (2008) Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs 22(10):877–886PubMedCrossRef Tuchman MM, Hee A, Emeribe U, Silberstein S (2008) Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs 22(10):877–886PubMedCrossRef
186.
go back to reference Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G (1990) Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 30(11):705–709PubMedCrossRef Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G (1990) Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 30(11):705–709PubMedCrossRef
187.
go back to reference de Lignières BB, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG (1986) Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 293(6561):1540CrossRef de Lignières BB, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG (1986) Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 293(6561):1540CrossRef
188.
go back to reference Calhoun AH, Hutchinson S (2009) Hormonal therapies for menstrual migraine. Curr Pain Headache Rep 13(5):381–385 (review)PubMedCrossRef Calhoun AH, Hutchinson S (2009) Hormonal therapies for menstrual migraine. Curr Pain Headache Rep 13(5):381–385 (review)PubMedCrossRef
189.
go back to reference Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29(10):1021–1027 (epub 2009 Apr 23; review)PubMedCrossRef Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29(10):1021–1027 (epub 2009 Apr 23; review)PubMedCrossRef
190.
go back to reference Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J (2009) Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache 49(8):1153–1162PubMedCrossRef Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J (2009) Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache 49(8):1153–1162PubMedCrossRef
192.
go back to reference Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921–936 (epub 2010 May 7)PubMedCrossRef Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921–936 (epub 2010 May 7)PubMedCrossRef
193.
go back to reference Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G (2011) Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12(4):427–433 (epub 2011 Apr 16)PubMedCentralPubMedCrossRef Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G (2011) Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12(4):427–433 (epub 2011 Apr 16)PubMedCentralPubMedCrossRef
195.
go back to reference Langemark M, Olesen J (1987) Effervescent ASA versus solid ASA in the treatment of tension headache. A double blind, placebo controlled study. Headache 27(2):90–95PubMedCrossRef Langemark M, Olesen J (1987) Effervescent ASA versus solid ASA in the treatment of tension headache. A double blind, placebo controlled study. Headache 27(2):90–95PubMedCrossRef
196.
go back to reference Peters BH, Fraim CJ, Masel BE (1983) Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 74:36–42PubMedCrossRef Peters BH, Fraim CJ, Masel BE (1983) Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 74:36–42PubMedCrossRef
197.
go back to reference Kubitzeka F, Zieglerb G, Gold MS, Liu JM, Ionescud E (2003) Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 7:155–162CrossRef Kubitzeka F, Zieglerb G, Gold MS, Liu JM, Ionescud E (2003) Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 7:155–162CrossRef
198.
go back to reference Lange R, Lentz R (1995) Comparison of ketoprofen, ibuprofen and naproxene sodium in the treatment of tension type headache. Drugs Exp Clin Res 21(3):89–96PubMed Lange R, Lentz R (1995) Comparison of ketoprofen, ibuprofen and naproxene sodium in the treatment of tension type headache. Drugs Exp Clin Res 21(3):89–96PubMed
199.
go back to reference Diamond S (1983) Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 23:206–210PubMedCrossRef Diamond S (1983) Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 23:206–210PubMedCrossRef
200.
go back to reference Mehlisch DR, Weaver M, Fladung B (1988) Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 38(8):579–589CrossRef Mehlisch DR, Weaver M, Fladung B (1988) Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 38(8):579–589CrossRef
201.
go back to reference Martinez-Martin P, Raffaelli E Jr, Titus F, Despuig J, Fragoso YD, Diez-Tejedor E, Liano H, Leira R, Cornet ME, van Toor BSJ, Camara J, Peil H, Vix JM, Ortiz P, and the Co-operative Study Group (2001) Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomised, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 21:604–610PubMedCrossRef Martinez-Martin P, Raffaelli E Jr, Titus F, Despuig J, Fragoso YD, Diez-Tejedor E, Liano H, Leira R, Cornet ME, van Toor BSJ, Camara J, Peil H, Vix JM, Ortiz P, and the Co-operative Study Group (2001) Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomised, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 21:604–610PubMedCrossRef
202.
go back to reference Ramacciotti AS, Soares BG, Atallah AN (2007) Dipyrone for acute primary headaches. Cochrane Database Syst Rev 18(2):CD004842 Ramacciotti AS, Soares BG, Atallah AN (2007) Dipyrone for acute primary headaches. Cochrane Database Syst Rev 18(2):CD004842
203.
go back to reference Bigal ME, Bordini CA, Speciali JG (2002) Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study. Braz J Med Biol Res 35(10):1139–1145 Bigal ME, Bordini CA, Speciali JG (2002) Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study. Braz J Med Biol Res 35(10):1139–1145
204.
go back to reference Prior MJ, Cooper KM, May LG, Bowen DL (2002) Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 22:740–748PubMedCrossRef Prior MJ, Cooper KM, May LG, Bowen DL (2002) Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 22:740–748PubMedCrossRef
205.
go back to reference Steiner TJ, Lange R, Voelker M (2003) Aspirin in episodic tension-type headache: placebo controlled dose-ranging comparison with paracetamol. Cephalalgia 23:59–66PubMedCrossRef Steiner TJ, Lange R, Voelker M (2003) Aspirin in episodic tension-type headache: placebo controlled dose-ranging comparison with paracetamol. Cephalalgia 23:59–66PubMedCrossRef
206.
go back to reference Diamond S, Freitag FG, Balm TK, Berry DA (1997) The use of a combination agent of ibuprofen and caffeine in the treatment of episodic tension-type headache. Cephalalgia 17:466 Diamond S, Freitag FG, Balm TK, Berry DA (1997) The use of a combination agent of ibuprofen and caffeine in the treatment of episodic tension-type headache. Cephalalgia 17:466
207.
go back to reference Diamond S, Balm TK, Freitag FG (2000) Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 68:312–319PubMedCrossRef Diamond S, Balm TK, Freitag FG (2000) Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 68:312–319PubMedCrossRef
208.
go back to reference Migliardi JR, Armellino JJ, Friedman M, Gillings BD, Beaver WT (1994) Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 56:576–586PubMedCrossRef Migliardi JR, Armellino JJ, Friedman M, Gillings BD, Beaver WT (1994) Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 56:576–586PubMedCrossRef
209.
go back to reference Pini LA, Del Bene E, Zanchin G, Sarchielli P, Di Trapani G, Prudenzano MP, LaPegna G, Savi L, Di Loreto G, Dionisio P, Granella F (2008) Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium. J Headache Pain 9(6):367–373PubMedCentralPubMedCrossRef Pini LA, Del Bene E, Zanchin G, Sarchielli P, Di Trapani G, Prudenzano MP, LaPegna G, Savi L, Di Loreto G, Dionisio P, Granella F (2008) Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium. J Headache Pain 9(6):367–373PubMedCentralPubMedCrossRef
210.
go back to reference Diener HC, Pfanferath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of asa, paracetamol and caffeine is more effective than single substance and dual combination for the treatment of headache: a multicentre, randomized, double blind, single dose, placebo controlled parallel group study. Cephalalgia 25:766–787 Diener HC, Pfanferath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of asa, paracetamol and caffeine is more effective than single substance and dual combination for the treatment of headache: a multicentre, randomized, double blind, single dose, placebo controlled parallel group study. Cephalalgia 25:766–787
211.
go back to reference Friedman AP, Di Serio FJ (1987) Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. Clin Ther 10(1):69–81PubMed Friedman AP, Di Serio FJ (1987) Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. Clin Ther 10(1):69–81PubMed
212.
go back to reference Silberstein SD, McCrory DC (2001) Butalbital in the treatment of headache: history, pharmacology and efficacy. Cephalalgia 41:953–957 Silberstein SD, McCrory DC (2001) Butalbital in the treatment of headache: history, pharmacology and efficacy. Cephalalgia 41:953–957
213.
go back to reference Cicek M, Karcioglu O, Parlak I, Ozturk V, Duman O, Serinken M, Guryay M (2004) Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emerg Med J 21:323–326PubMedCentralPubMedCrossRef Cicek M, Karcioglu O, Parlak I, Ozturk V, Duman O, Serinken M, Guryay M (2004) Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emerg Med J 21:323–326PubMedCentralPubMedCrossRef
214.
go back to reference Bigal ME, Bordini CA, Speciali JG (2002) Intravenous chlorpromazine in the acute treatment of episodic tension-type headache. Arq Neuropsiquiatr 60(3-A):537–541 Bigal ME, Bordini CA, Speciali JG (2002) Intravenous chlorpromazine in the acute treatment of episodic tension-type headache. Arq Neuropsiquiatr 60(3-A):537–541
215.
go back to reference Gobel H, Schmidt G, Soyka D (1994) Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 14:228–234PubMedCrossRef Gobel H, Schmidt G, Soyka D (1994) Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 14:228–234PubMedCrossRef
216.
go back to reference Gobel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996) Effectiveness of oleum menthae piperitae and paracetamol in therapy of headache of the tension type [German]. Nervenarzt 67:672–681PubMedCrossRef Gobel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996) Effectiveness of oleum menthae piperitae and paracetamol in therapy of headache of the tension type [German]. Nervenarzt 67:672–681PubMedCrossRef
217.
go back to reference Schattner P, Randerson D. (1996) Tiger Balm as a treatment of tension headache. A clinical trial in general practice. Aust Fam Physician 25(2):216, 218, 220 Schattner P, Randerson D. (1996) Tiger Balm as a treatment of tension headache. A clinical trial in general practice. Aust Fam Physician 25(2):216, 218, 220
218.
go back to reference Wöber C, Holzhammer J, Zeitlhofer J, Wessely P, Wöber-Bingöl C (2006) Trigger factors of migraine and tension-type headache: experience and knowledge of the patients. J Headache Pain 7(4):188–195 (epub 2006 Aug 11)PubMedCentralPubMedCrossRef Wöber C, Holzhammer J, Zeitlhofer J, Wessely P, Wöber-Bingöl C (2006) Trigger factors of migraine and tension-type headache: experience and knowledge of the patients. J Headache Pain 7(4):188–195 (epub 2006 Aug 11)PubMedCentralPubMedCrossRef
219.
go back to reference Gobel H, Hamouz V, Hansen C, Heiningen K, Hirsch S, Lindner V, Heuss D, Soyka D (1994) Amitriptyline in therapy of chronic tension headache. Nervenarzt 65(10):670–679PubMed Gobel H, Hamouz V, Hansen C, Heiningen K, Hirsch S, Lindner V, Heuss D, Soyka D (1994) Amitriptyline in therapy of chronic tension headache. Nervenarzt 65(10):670–679PubMed
220.
go back to reference Mitsikostas DD, Gatzonis S, Thomas A, Ilias A (1997) Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 96(4):247–251PubMedCrossRef Mitsikostas DD, Gatzonis S, Thomas A, Ilias A (1997) Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 96(4):247–251PubMedCrossRef
221.
go back to reference Langemark M, Loldrup D, Bech P, Olesen J (1990) Clomipramine and Mianserin in the treatment of chronic tension headache. A double blind, controlled study. Headache 30:118–121PubMedCrossRef Langemark M, Loldrup D, Bech P, Olesen J (1990) Clomipramine and Mianserin in the treatment of chronic tension headache. A double blind, controlled study. Headache 30:118–121PubMedCrossRef
222.
go back to reference Walker Z, Walker RW, Robertson MM, Stansfeld S (1998) Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache 38(7):523–528PubMedCrossRef Walker Z, Walker RW, Robertson MM, Stansfeld S (1998) Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache 38(7):523–528PubMedCrossRef
223.
go back to reference Tomkins GE, Jackson JL, O’Malley PG, Balden E, Santoro JE (2001) Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 11:54–63CrossRef Tomkins GE, Jackson JL, O’Malley PG, Balden E, Santoro JE (2001) Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 11:54–63CrossRef
224.
go back to reference Moja PL, Cusi C, Sterzi RR, Canepari C (2006) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches (Review) II. Copyright © The Cochrane Collaboration. Wiley, NY Moja PL, Cusi C, Sterzi RR, Canepari C (2006) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches (Review) II. Copyright © The Cochrane Collaboration. Wiley, NY
225.
go back to reference Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62:1706–1711PubMedCrossRef Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62:1706–1711PubMedCrossRef
226.
go back to reference Martín-Araguz A, Bustamante-Martínez C, de Pedro-Pijoán JM (2003) Treatment of chronic tension type headache with mirtazapine and amitriptyline. Rev Neurol 37(2):101–105PubMed Martín-Araguz A, Bustamante-Martínez C, de Pedro-Pijoán JM (2003) Treatment of chronic tension type headache with mirtazapine and amitriptyline. Rev Neurol 37(2):101–105PubMed
227.
go back to reference Adelman LC, Adelman JU, Von Seggern R, Mannix LK (2000) Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 40(7):572–580PubMedCrossRef Adelman LC, Adelman JU, Von Seggern R, Mannix LK (2000) Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 40(7):572–580PubMedCrossRef
228.
go back to reference Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou K (2007) A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27:315–324PubMedCrossRef Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou K (2007) A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27:315–324PubMedCrossRef
229.
go back to reference Manna V, Bolino F, Di Cicco L (1994) Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 34:44–49PubMedCrossRef Manna V, Bolino F, Di Cicco L (1994) Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 34:44–49PubMedCrossRef
230.
go back to reference Fogelholm R, Murros K (1985) Maprotiline in chronic tension headache: a double-blind crossover study. Headache 25:273–275PubMedCrossRef Fogelholm R, Murros K (1985) Maprotiline in chronic tension headache: a double-blind crossover study. Headache 25:273–275PubMedCrossRef
231.
go back to reference Saper JR, Lake AE, Tepper SJ (2001) Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache 41(5):465–474PubMedCrossRef Saper JR, Lake AE, Tepper SJ (2001) Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache 41(5):465–474PubMedCrossRef
232.
go back to reference Nappi G, Sandrini G, Granella F, Ruiz L, Cerutti G, Facchinetti F, Blandini F, Manzoni GC (1990) A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. Headache 30(7):439–444PubMedCrossRef Nappi G, Sandrini G, Granella F, Ruiz L, Cerutti G, Facchinetti F, Blandini F, Manzoni GC (1990) A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. Headache 30(7):439–444PubMedCrossRef
233.
go back to reference Ansink BJ, Hartman JW, Smakman JG (1992) Ritanserin is not effective in tension headache. Headache 32(6):314PubMedCrossRef Ansink BJ, Hartman JW, Smakman JG (1992) Ritanserin is not effective in tension headache. Headache 32(6):314PubMedCrossRef
234.
go back to reference Langemark M, Olesen J (1994) Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 34(1):20PubMedCrossRef Langemark M, Olesen J (1994) Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 34(1):20PubMedCrossRef
235.
go back to reference Fogelholm R, Murros K (1992) Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 32:509–513PubMedCrossRef Fogelholm R, Murros K (1992) Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 32:509–513PubMedCrossRef
236.
go back to reference Saper JR, Lake AE, Cantrell DT, Winner PK, White JR (2002) Chronic Daily Headache prophylaxis with tizanidine. A double-blind, placebo-controlled, multicentric outcome study. Headache 42:470–482PubMedCrossRef Saper JR, Lake AE, Cantrell DT, Winner PK, White JR (2002) Chronic Daily Headache prophylaxis with tizanidine. A double-blind, placebo-controlled, multicentric outcome study. Headache 42:470–482PubMedCrossRef
237.
go back to reference Lance JW, Anthony M (1972) Cyclobenzaprine in the treatment of chronic tension headache. Med J Aust 2(25):1409–1411PubMed Lance JW, Anthony M (1972) Cyclobenzaprine in the treatment of chronic tension headache. Med J Aust 2(25):1409–1411PubMed
238.
go back to reference Paiva T, Nunes JS, Moreira A, Santos J, Texeira J, Barbosa A (1982) Effects of frontalis EMG biofeedback and diazepam in the treatment of tension headache. Headache 22(5):216–220PubMedCrossRef Paiva T, Nunes JS, Moreira A, Santos J, Texeira J, Barbosa A (1982) Effects of frontalis EMG biofeedback and diazepam in the treatment of tension headache. Headache 22(5):216–220PubMedCrossRef
239.
go back to reference Weber MB (1973) The treatment of muscle contraction headache with diazepam. Curr Ther Res 15:210–216PubMed Weber MB (1973) The treatment of muscle contraction headache with diazepam. Curr Ther Res 15:210–216PubMed
240.
go back to reference Shukla R, Nag D, Ahuja RC (1996) Alprazolam in chronic tension type headache. J Assoc Physicians India 44(9):641–644PubMed Shukla R, Nag D, Ahuja RC (1996) Alprazolam in chronic tension type headache. J Assoc Physicians India 44(9):641–644PubMed
241.
go back to reference Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term, study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26:1203–1208PubMedCrossRef Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term, study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26:1203–1208PubMedCrossRef
242.
go back to reference Ribeiro CA (2000) L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. Headache 40(6):451–456PubMedCrossRef Ribeiro CA (2000) L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. Headache 40(6):451–456PubMedCrossRef
243.
go back to reference Rozen D, Sharma J (2006) Treatment of tension-type headache with botox: a review of the literature. Mt Sinai J Med 73(1):493–498 (review)PubMed Rozen D, Sharma J (2006) Treatment of tension-type headache with botox: a review of the literature. Mt Sinai J Med 73(1):493–498 (review)PubMed
244.
go back to reference Schulte-Mattler WJ, Leinisch E (2008) Evidence based medicine on the use of botulinum toxin for headache disorders. J Neural Transm 115(4):647–651PubMedCrossRef Schulte-Mattler WJ, Leinisch E (2008) Evidence based medicine on the use of botulinum toxin for headache disorders. J Neural Transm 115(4):647–651PubMedCrossRef
245.
go back to reference Halker R, Vargas B, Dodick DW (2010) Cluster headache: diagnosis and treatment. Semin Neurol 30(2):175–185 (epub 2010 Mar 29)PubMedCrossRef Halker R, Vargas B, Dodick DW (2010) Cluster headache: diagnosis and treatment. Semin Neurol 30(2):175–185 (epub 2010 Mar 29)PubMedCrossRef
246.
go back to reference Goadsby PJ, Cittadini E, Burns B, Cohen AS (2008) Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol 21(3):323–330PubMedCrossRef Goadsby PJ, Cittadini E, Burns B, Cohen AS (2008) Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol 21(3):323–330PubMedCrossRef
247.
go back to reference May A (2006) Update on the diagnosis and management of trigemino-autonomic headaches. J Neurol 253(12):1525–1532PubMedCrossRef May A (2006) Update on the diagnosis and management of trigemino-autonomic headaches. J Neurol 253(12):1525–1532PubMedCrossRef
248.
go back to reference The Sumatriptan Cluster Headache Study Group (1991) Treatment of acute cluster headache with sumatriptan. N Engl J Med 325:322–326CrossRef The Sumatriptan Cluster Headache Study Group (1991) Treatment of acute cluster headache with sumatriptan. N Engl J Med 325:322–326CrossRef
249.
go back to reference Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D (1993) Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand 88:63–69PubMedCrossRef Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D (1993) Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand 88:63–69PubMedCrossRef
250.
go back to reference Gregor N, Schlesiger C, Akova-Öztürk E, Kraemer C, Husstedt I-W, Evers S (2005) Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan. Headache 45:1069–1072PubMedCrossRef Gregor N, Schlesiger C, Akova-Öztürk E, Kraemer C, Husstedt I-W, Evers S (2005) Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan. Headache 45:1069–1072PubMedCrossRef
251.
go back to reference Ekbom K, Krabbe A, Micelli G, Prusinski A, cole JA, Pilgrim AJ, Noronha J, for the Sumatriptan Cluster Headache Long-term Study Group (1995) Cluster headache attacks treated for up three months with subcutaneous sumatriptan (6 mg). Cephalalgia 15:230–236PubMedCrossRef Ekbom K, Krabbe A, Micelli G, Prusinski A, cole JA, Pilgrim AJ, Noronha J, for the Sumatriptan Cluster Headache Long-term Study Group (1995) Cluster headache attacks treated for up three months with subcutaneous sumatriptan (6 mg). Cephalalgia 15:230–236PubMedCrossRef
252.
go back to reference Göbel H, Lindner A, Heinze A, Ribbat M, Deuschl G (1998) Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 51:908–911PubMedCrossRef Göbel H, Lindner A, Heinze A, Ribbat M, Deuschl G (1998) Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 51:908–911PubMedCrossRef
253.
go back to reference Van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ (2003) Intranasal sumatriptan in cluster headache. Randomized placebo-controlled double-blind study. Neurology 60:630–633PubMedCrossRef Van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ (2003) Intranasal sumatriptan in cluster headache. Randomized placebo-controlled double-blind study. Neurology 60:630–633PubMedCrossRef
254.
go back to reference Law S, Derry S, Moore RA (2010) Triptans for acute cluster headache. Cochrane Database Syst Rev (4):CD008042 Law S, Derry S, Moore RA (2010) Triptans for acute cluster headache. Cochrane Database Syst Rev (4):CD008042
255.
go back to reference Bahra A, Gawel MJ, Hardebo J-E, Millson D, Breen SA, Goadsby PJ (2000) Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 54:1832–1839PubMedCrossRef Bahra A, Gawel MJ, Hardebo J-E, Millson D, Breen SA, Goadsby PJ (2000) Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 54:1832–1839PubMedCrossRef
256.
go back to reference Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ (2006) Effectiveness of intranasal zolmitriptan in acute cluster headache. A randomized, placebo-controlled, double-blind crossover study. Arch Neurol 63:1537–1542PubMedCrossRef Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ (2006) Effectiveness of intranasal zolmitriptan in acute cluster headache. A randomized, placebo-controlled, double-blind crossover study. Arch Neurol 63:1537–1542PubMedCrossRef
257.
go back to reference Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, Bigal ME (2007) Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 69:821–826PubMedCrossRef Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, Bigal ME (2007) Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 69:821–826PubMedCrossRef
258.
go back to reference Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ (2009) Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 49(9):1315–1323PubMedCrossRef Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ (2009) Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 49(9):1315–1323PubMedCrossRef
259.
go back to reference Fogan L (1985) Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol 42:362–363PubMedCrossRef Fogan L (1985) Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol 42:362–363PubMedCrossRef
260.
go back to reference Cohen AS, Burns B, Goadsby PJ (2009) High-flow oxygen for treatment of cluster headache. JAMA 302:2451–2457PubMedCrossRef Cohen AS, Burns B, Goadsby PJ (2009) High-flow oxygen for treatment of cluster headache. JAMA 302:2451–2457PubMedCrossRef
262.
go back to reference Horton BT, Ryan R, Reynolds JR (1948) Clinical observations on the use of E.C. 110, a new agent for the treatment of headache. Mayo Clin Proc 23:105–108 Horton BT, Ryan R, Reynolds JR (1948) Clinical observations on the use of E.C. 110, a new agent for the treatment of headache. Mayo Clin Proc 23:105–108
263.
go back to reference Magee KR, Westerberg MR, DeJong RM (1952) Treatment of headache with ergotamine-caffeine suppositories. Neurology 2:477–480PubMedCrossRef Magee KR, Westerberg MR, DeJong RM (1952) Treatment of headache with ergotamine-caffeine suppositories. Neurology 2:477–480PubMedCrossRef
264.
go back to reference Speed WG (1960) Ergotamine tartrate inhalation: a new approach to the management of recurrent vascular headaches. Am J Med Sci 240:327–331PubMedCrossRef Speed WG (1960) Ergotamine tartrate inhalation: a new approach to the management of recurrent vascular headaches. Am J Med Sci 240:327–331PubMedCrossRef
265.
go back to reference Graham JR, Malvea BP, Gramm HF (1960) Aerosol ergotamine tartrate for migraine and Horton’s syndrome. N Engl J Med 263:802–804PubMedCrossRef Graham JR, Malvea BP, Gramm HF (1960) Aerosol ergotamine tartrate for migraine and Horton’s syndrome. N Engl J Med 263:802–804PubMedCrossRef
266.
go back to reference Andersson PG, Jespersen LT (1986) Dihydroergotamine nasal spray in the treatment of attacks of cluster headaches. Cephalalgia 6:51–54PubMedCrossRef Andersson PG, Jespersen LT (1986) Dihydroergotamine nasal spray in the treatment of attacks of cluster headaches. Cephalalgia 6:51–54PubMedCrossRef
267.
go back to reference Kittrelle JP, Grouse DS, Seybold ME (1985) Cluster headache. Local anesthetic abortive agents. Arch Neurol 42:496–498PubMedCrossRef Kittrelle JP, Grouse DS, Seybold ME (1985) Cluster headache. Local anesthetic abortive agents. Arch Neurol 42:496–498PubMedCrossRef
269.
go back to reference Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, Nappi G (2000) The effect of intranasal cocaina and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia 20:85–91PubMedCrossRef Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, Nappi G (2000) The effect of intranasal cocaina and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia 20:85–91PubMedCrossRef
270.
go back to reference Barre’ F (1982) Cocaine as an abortive agent in cluster headache. Headache 22:69–73CrossRef Barre’ F (1982) Cocaine as an abortive agent in cluster headache. Headache 22:69–73CrossRef
271.
go back to reference Sicuteri F, Geppetti P, Marabini S, Lembeck F (1984) Pain relief by somatostatin in attacks of cluster headache. Pain 18(4):359–365PubMedCrossRef Sicuteri F, Geppetti P, Marabini S, Lembeck F (1984) Pain relief by somatostatin in attacks of cluster headache. Pain 18(4):359–365PubMedCrossRef
272.
go back to reference Matharu MS, Levy MJ, Meeran K, Goadsby PJ (2004) Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol 56:488–494PubMedCrossRef Matharu MS, Levy MJ, Meeran K, Goadsby PJ (2004) Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol 56:488–494PubMedCrossRef
273.
go back to reference Francis GJ, Becker WJ, Pringsheim TM (2010) Acute and preventive pharmacologic treatment of cluster headache. Neurology 75(5):463–473PubMedCrossRef Francis GJ, Becker WJ, Pringsheim TM (2010) Acute and preventive pharmacologic treatment of cluster headache. Neurology 75(5):463–473PubMedCrossRef
274.
go back to reference Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, Bussone G (2000) Verapamil in the prophylaxis of episodic cluster headache: a double–blind study versus placebo. Neurology 54:1382–1385PubMedCrossRef Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, Bussone G (2000) Verapamil in the prophylaxis of episodic cluster headache: a double–blind study versus placebo. Neurology 54:1382–1385PubMedCrossRef
275.
go back to reference Gabai IJ, Spierings ELH (1989) Prophylactic treatment of cluster headache with verapamil. Headache 29:167–168PubMedCrossRef Gabai IJ, Spierings ELH (1989) Prophylactic treatment of cluster headache with verapamil. Headache 29:167–168PubMedCrossRef
276.
go back to reference Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, Manzoni GC, Nappi G (1990) Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 30:411–417PubMedCrossRef Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, Manzoni GC, Nappi G (1990) Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 30:411–417PubMedCrossRef
277.
go back to reference Blau JN, Engel HO (2004) Individualizing treatment with verapamil for cluster headache patients. Headache 44:1013–1018PubMedCrossRef Blau JN, Engel HO (2004) Individualizing treatment with verapamil for cluster headache patients. Headache 44:1013–1018PubMedCrossRef
278.
279.
go back to reference Cohen AS, Matharu MS, Goadsby PJ (2007) Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 69(7):668–675PubMedCrossRef Cohen AS, Matharu MS, Goadsby PJ (2007) Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 69(7):668–675PubMedCrossRef
280.
go back to reference Ekbom K (1981) Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 21:132–139PubMedCrossRef Ekbom K (1981) Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 21:132–139PubMedCrossRef
281.
go back to reference Steiner TJ, Hering R, Couturier EGM, Davies PTG, Whitmarsh TE (1997) Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia 17:673–675PubMedCrossRef Steiner TJ, Hering R, Couturier EGM, Davies PTG, Whitmarsh TE (1997) Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia 17:673–675PubMedCrossRef
282.
go back to reference Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217–222PubMedCrossRef Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217–222PubMedCrossRef
283.
284.
go back to reference Mir P, Alberca R, Navarro A, Montes E, Martínez E, Franco E, Cayuela A, Lozano P (2003) Prophylactic treatment of episodic cluster headache with intravenous bolus of metilprednisolone. Neurol Sci 24:318–321PubMedCrossRef Mir P, Alberca R, Navarro A, Montes E, Martínez E, Franco E, Cayuela A, Lozano P (2003) Prophylactic treatment of episodic cluster headache with intravenous bolus of metilprednisolone. Neurol Sci 24:318–321PubMedCrossRef
285.
go back to reference Antonaci F, Costa A, Candeloro E, Sjaastad O, Nappi G (2005) Single high dose steroid treatment in episodic cluster headache. Cephalalgia 25:290–295PubMedCrossRef Antonaci F, Costa A, Candeloro E, Sjaastad O, Nappi G (2005) Single high dose steroid treatment in episodic cluster headache. Cephalalgia 25:290–295PubMedCrossRef
286.
go back to reference Curran DA, Hinterberger H, Lance JW (1967) Methysergide. Res Clin Stud Headache 1:74–122 Curran DA, Hinterberger H, Lance JW (1967) Methysergide. Res Clin Stud Headache 1:74–122
287.
go back to reference Lovshin LL (1963) Treatment on histaminic cephalalgia with Methysergide (UML-491) (based on 159 cases). Dis Nerv Syst 24:120–124 Lovshin LL (1963) Treatment on histaminic cephalalgia with Methysergide (UML-491) (based on 159 cases). Dis Nerv Syst 24:120–124
288.
go back to reference Graham J, Suby H, Le Compte P, Sadowsky N (1966) Fibrotic disorders associated with methysergide therapy for headache. New Engl J Med 270:67–72CrossRef Graham J, Suby H, Le Compte P, Sadowsky N (1966) Fibrotic disorders associated with methysergide therapy for headache. New Engl J Med 270:67–72CrossRef
289.
go back to reference Ekbom K (1969) Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurol Scandinav 45:601–610PubMedCrossRef Ekbom K (1969) Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurol Scandinav 45:601–610PubMedCrossRef
290.
go back to reference Raffaelli E, Martins OJ, dos Santos P, Dágua Filho A (1983) Lisuride in cluster headache. Headache 23:117–121PubMedCrossRef Raffaelli E, Martins OJ, dos Santos P, Dágua Filho A (1983) Lisuride in cluster headache. Headache 23:117–121PubMedCrossRef
291.
go back to reference Hering R, Kuritzky A (1989) Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 9:195–198PubMedCrossRef Hering R, Kuritzky A (1989) Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 9:195–198PubMedCrossRef
292.
go back to reference El Amrani M, Massiou H, Bousser MG (2002) A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia 22:205–208PubMedCrossRef El Amrani M, Massiou H, Bousser MG (2002) A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia 22:205–208PubMedCrossRef
293.
294.
go back to reference Láinez MJA, Pascual J, Pascual AM, Santonja JM, Ponz A, Salvador A (2003) Topiramate in the prophylactic treatment of cluster headache. Headache 43:784–789PubMedCrossRef Láinez MJA, Pascual J, Pascual AM, Santonja JM, Ponz A, Salvador A (2003) Topiramate in the prophylactic treatment of cluster headache. Headache 43:784–789PubMedCrossRef
295.
go back to reference Leone M, Dodick D, Rigamonti A, D’Amico D, Grazzi L, Mea E, Bussone G (2003) Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia 23:1001–1002PubMedCrossRef Leone M, Dodick D, Rigamonti A, D’Amico D, Grazzi L, Mea E, Bussone G (2003) Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia 23:1001–1002PubMedCrossRef
296.
go back to reference Ahmed F (2000) Chronic cluster headache responding to gabapentin: a case report. Cephalalgia 20:252–253PubMedCrossRef Ahmed F (2000) Chronic cluster headache responding to gabapentin: a case report. Cephalalgia 20:252–253PubMedCrossRef
297.
go back to reference Leandri M, Luzzani M, Cruccu G, Gottlieb A (2001) Drug-resistant cluster headache responding to gabapentin: a pilot study. Cephalalgia 21:744–746PubMedCrossRef Leandri M, Luzzani M, Cruccu G, Gottlieb A (2001) Drug-resistant cluster headache responding to gabapentin: a pilot study. Cephalalgia 21:744–746PubMedCrossRef
298.
go back to reference Schuh-Hofer S, Israel H, Neeb L, Reuter U, Arnold G (2007) The use of gabapentin in chronic cluster headache patients refractory to first-line therapy. Eur J Neurol 14:694–696PubMedCrossRef Schuh-Hofer S, Israel H, Neeb L, Reuter U, Arnold G (2007) The use of gabapentin in chronic cluster headache patients refractory to first-line therapy. Eur J Neurol 14:694–696PubMedCrossRef
299.
go back to reference Vukovic V, Lovrencic-Huzjan A, Budišic M, Demarin V (2009) Gabapentin in the prophylaxis of cluster headache: an observational open label study. Acta Clin Croat 48:311–314PubMed Vukovic V, Lovrencic-Huzjan A, Budišic M, Demarin V (2009) Gabapentin in the prophylaxis of cluster headache: an observational open label study. Acta Clin Croat 48:311–314PubMed
301.
go back to reference Mather PJ, Silberstein SD, Schulman EA, Mc Fadden Hopkins M (1991) The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache 31:525–532PubMedCrossRef Mather PJ, Silberstein SD, Schulman EA, Mc Fadden Hopkins M (1991) The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache 31:525–532PubMedCrossRef
302.
go back to reference Magnoux E, Zlotnik G (2004) Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache 44:249–255PubMedCrossRef Magnoux E, Zlotnik G (2004) Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache 44:249–255PubMedCrossRef
303.
go back to reference Diamond S, Freitag FG, Prager J, Gandhi S (1986) Treatment of intractable cluster. Headache 26:42–46PubMedCrossRef Diamond S, Freitag FG, Prager J, Gandhi S (1986) Treatment of intractable cluster. Headache 26:42–46PubMedCrossRef
304.
go back to reference Siow HC, Pozo-Rosich P, Silberstein SD (2004) Frovatriptan for the treatment of cluster headaches. Cephalalgia 24:1045–1048PubMedCrossRef Siow HC, Pozo-Rosich P, Silberstein SD (2004) Frovatriptan for the treatment of cluster headaches. Cephalalgia 24:1045–1048PubMedCrossRef
305.
go back to reference Zebenholzer K, Wöber C, Vigl M, Wessely P (2004) Eletriptan for the short-term prophylaxis of cluster headache. Headache 44:361–364PubMedCrossRef Zebenholzer K, Wöber C, Vigl M, Wessely P (2004) Eletriptan for the short-term prophylaxis of cluster headache. Headache 44:361–364PubMedCrossRef
306.
go back to reference Monstad I, Krabbe A, Micieli G, Prusinski A, Cole J, Pilgrim A, Shevlin P (1995) Preemptive oral treatment with sumatriptan during a cluster period. Headache 35:607–613PubMedCrossRef Monstad I, Krabbe A, Micieli G, Prusinski A, Cole J, Pilgrim A, Shevlin P (1995) Preemptive oral treatment with sumatriptan during a cluster period. Headache 35:607–613PubMedCrossRef
307.
go back to reference Sicuteri F, Fusco BM, Marabini S, Camapagnolo V, Maggi CA, Geppetti P, Fanciullacci M (1989) Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain 5:49–53PubMedCrossRef Sicuteri F, Fusco BM, Marabini S, Camapagnolo V, Maggi CA, Geppetti P, Fanciullacci M (1989) Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain 5:49–53PubMedCrossRef
308.
go back to reference Fusco BM, Marabini S, Maggi CA, Fiore G, Geppeti P (1994) Preventive effect of repeated nasal applications of capsaicin in cluster headache. Pain 59:321–325PubMedCrossRef Fusco BM, Marabini S, Maggi CA, Fiore G, Geppeti P (1994) Preventive effect of repeated nasal applications of capsaicin in cluster headache. Pain 59:321–325PubMedCrossRef
309.
go back to reference Chazot G, Claustrat B, Brun J, Sassolas G, Schott B (1984) A chronobiological study on melatonin, cortisol, growth hormone and prolactin secretion in cluster headache. Cephalalgia 4:213–220PubMedCrossRef Chazot G, Claustrat B, Brun J, Sassolas G, Schott B (1984) A chronobiological study on melatonin, cortisol, growth hormone and prolactin secretion in cluster headache. Cephalalgia 4:213–220PubMedCrossRef
310.
go back to reference Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G (1996) Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 16:494–496PubMedCrossRef Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G (1996) Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 16:494–496PubMedCrossRef
311.
go back to reference Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aubé M (2002) Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache 42:787–792PubMedCrossRef Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aubé M (2002) Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache 42:787–792PubMedCrossRef
312.
go back to reference Sjaastad O, Vincent M (2010) Indomethacin responsive headache syndromes: chronic paroxysmal hemicrania and hemicrania continua. How they were discovered and what we have learned since. Funct Neurol 25(1):49–55PubMed Sjaastad O, Vincent M (2010) Indomethacin responsive headache syndromes: chronic paroxysmal hemicrania and hemicrania continua. How they were discovered and what we have learned since. Funct Neurol 25(1):49–55PubMed
313.
go back to reference Pareja JA, Caminero AB, Franco E, Casado JL, Pascual J, Sánchez del Río M (2001) Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 21(9):906–910PubMedCrossRef Pareja JA, Caminero AB, Franco E, Casado JL, Pascual J, Sánchez del Río M (2001) Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 21(9):906–910PubMedCrossRef
314.
go back to reference May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ, EFNS Task Force (2006) EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 13:1066PubMedCrossRef May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ, EFNS Task Force (2006) EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 13:1066PubMedCrossRef
315.
go back to reference Porta-Etessam J, Cuadrado M, Rodríguez-Gómez O, García-Ptacek S, Valencia C (2010) Are Cox-2 drugs the second line option in indomethacin responsive headaches? J Headache Pain 11(5):405–407PubMedCentralPubMedCrossRef Porta-Etessam J, Cuadrado M, Rodríguez-Gómez O, García-Ptacek S, Valencia C (2010) Are Cox-2 drugs the second line option in indomethacin responsive headaches? J Headache Pain 11(5):405–407PubMedCentralPubMedCrossRef
316.
go back to reference Sjaastad O, Antonaci F (1995) A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 35(9):549–550PubMedCrossRef Sjaastad O, Antonaci F (1995) A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 35(9):549–550PubMedCrossRef
317.
go back to reference Lisotto C, Maggioni F, Mainardi F, Zanchin G (2003) Rofecoxib for the treatment of chronic paroxysaml emicrania. Cephalagia 23(4):318–320CrossRef Lisotto C, Maggioni F, Mainardi F, Zanchin G (2003) Rofecoxib for the treatment of chronic paroxysaml emicrania. Cephalagia 23(4):318–320CrossRef
318.
go back to reference Siow HC (2004) Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 24(5):414–415PubMedCrossRef Siow HC (2004) Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 24(5):414–415PubMedCrossRef
319.
go back to reference Mathew NT, Kailasam J, Fischer A (2000) Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 55(2):316PubMedCrossRef Mathew NT, Kailasam J, Fischer A (2000) Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 55(2):316PubMedCrossRef
320.
go back to reference Evers S, Husstedt IW (1996) Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 36(7):429–432PubMedCrossRef Evers S, Husstedt IW (1996) Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 36(7):429–432PubMedCrossRef
321.
go back to reference Bussone G, Rapoport A (2010) Acute and preventive treatment of cluster headache and other trigeminal autonomic cephalgias. Handb Clin Neurol 97:431–442PubMedCrossRef Bussone G, Rapoport A (2010) Acute and preventive treatment of cluster headache and other trigeminal autonomic cephalgias. Handb Clin Neurol 97:431–442PubMedCrossRef
322.
go back to reference Caminero AB, Pareja JA, Dobato JL (1998) Chronic paroxysmal hemicrania-tic syndrome. Cephalalgia 18(3):159–161PubMedCrossRef Caminero AB, Pareja JA, Dobato JL (1998) Chronic paroxysmal hemicrania-tic syndrome. Cephalalgia 18(3):159–161PubMedCrossRef
323.
go back to reference Martinez-Salio A, Porta-Etessam J, Perez-Martinez D, Balseiro J, Gutierrez-Rivas E (2000) Case reports: chronic paroxysmal hemicrania-tic syndrome. Headache 40(8):682–685PubMedCrossRef Martinez-Salio A, Porta-Etessam J, Perez-Martinez D, Balseiro J, Gutierrez-Rivas E (2000) Case reports: chronic paroxysmal hemicrania-tic syndrome. Headache 40(8):682–685PubMedCrossRef
324.
go back to reference Evans RW, Olesen J (2000) Remitting chronic paroxysmal hemicrania or episodic paroxysmal hemicrania? Headache 40(10):858–859PubMedCrossRef Evans RW, Olesen J (2000) Remitting chronic paroxysmal hemicrania or episodic paroxysmal hemicrania? Headache 40(10):858–859PubMedCrossRef
325.
go back to reference Hannerz J (1993) Trigeminal neuralgia with chronic paroxysmal hemicrania: the CPH-tic syndrome. Cephalalgia 13(5):361–364PubMedCrossRef Hannerz J (1993) Trigeminal neuralgia with chronic paroxysmal hemicrania: the CPH-tic syndrome. Cephalalgia 13(5):361–364PubMedCrossRef
326.
go back to reference Goadsby PJ, Edvinsson L (1996) Neuropeptide changes in a case of chronic paroxysmal hemicrania—evidence for trigemino-parasympathetic activation. Cephalalgia 16(6):448–450PubMedCrossRef Goadsby PJ, Edvinsson L (1996) Neuropeptide changes in a case of chronic paroxysmal hemicrania—evidence for trigemino-parasympathetic activation. Cephalalgia 16(6):448–450PubMedCrossRef
327.
go back to reference Mateo I, Pascual J (1999) Coexistence of chronic paroxysmal hemicrania and benign cough headache. Headache 39(6):437–438PubMedCrossRef Mateo I, Pascual J (1999) Coexistence of chronic paroxysmal hemicrania and benign cough headache. Headache 39(6):437–438PubMedCrossRef
328.
go back to reference Boes CJ, Swanson JW, Dodick DW (1998) Chronic paroxysmal hemicrania presenting as otalgia with a sensation of external acoustic meatus obstruction: two cases and a pathophysiologic hypothesis. Headache 38(10):787–791PubMedCrossRef Boes CJ, Swanson JW, Dodick DW (1998) Chronic paroxysmal hemicrania presenting as otalgia with a sensation of external acoustic meatus obstruction: two cases and a pathophysiologic hypothesis. Headache 38(10):787–791PubMedCrossRef
329.
go back to reference Pareja J, Pareja J (1992) Chronic paroxysmal hemicrania coexisting with migraine. Differential response to pharmacological treatment. Headache 32(2):77–78PubMedCrossRef Pareja J, Pareja J (1992) Chronic paroxysmal hemicrania coexisting with migraine. Differential response to pharmacological treatment. Headache 32(2):77–78PubMedCrossRef
330.
go back to reference Tehindrazanarivelo AD, Visy JM, Bousser MG (1992) Ipsilateral cluster headache and chronic paroxysmal hemicrania: two case reports. Cephalalgia 12(5):318–320PubMedCrossRef Tehindrazanarivelo AD, Visy JM, Bousser MG (1992) Ipsilateral cluster headache and chronic paroxysmal hemicrania: two case reports. Cephalalgia 12(5):318–320PubMedCrossRef
331.
332.
go back to reference Boes CJ, Matharu MS, Goadsby PJ (2003) The paroxysmal hemicrania-tic syndrome. Cephalalgia 23(1):24–28PubMedCrossRef Boes CJ, Matharu MS, Goadsby PJ (2003) The paroxysmal hemicrania-tic syndrome. Cephalalgia 23(1):24–28PubMedCrossRef
333.
go back to reference Rossi P, Cesarino F, Faroni J, Malpezzi MG, Sandrini G, Nappi G (2003) SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia 23(10):998–1000PubMedCrossRef Rossi P, Cesarino F, Faroni J, Malpezzi MG, Sandrini G, Nappi G (2003) SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia 23(10):998–1000PubMedCrossRef
334.
go back to reference Matharu MS, Boes CJ, Goadsby PJ (2002) SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology 58(8):1307PubMedCrossRef Matharu MS, Boes CJ, Goadsby PJ (2002) SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology 58(8):1307PubMedCrossRef
335.
go back to reference Calvo JF, Bruera OC, de Lourdes Figuerola M, Gestro D, Tinetti N, Leston JA (2004) SUNCT syndrome: clinical and 12-year follow-up case report. Cephalalgia 24(10):900–902PubMedCrossRef Calvo JF, Bruera OC, de Lourdes Figuerola M, Gestro D, Tinetti N, Leston JA (2004) SUNCT syndrome: clinical and 12-year follow-up case report. Cephalalgia 24(10):900–902PubMedCrossRef
336.
go back to reference Putzki N, Nirkko A, Diener HC (2005) Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome? Cephalalgia 25(5):395–397PubMedCrossRef Putzki N, Nirkko A, Diener HC (2005) Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome? Cephalalgia 25(5):395–397PubMedCrossRef
338.
340.
go back to reference Selekler HM, Efendi H, Alemdar M (2005) Short-lasting unilateral neuralgiform headache with severe lacrimation and mild conjunctival injection. Cephalalgia 25(4):317–320PubMedCrossRef Selekler HM, Efendi H, Alemdar M (2005) Short-lasting unilateral neuralgiform headache with severe lacrimation and mild conjunctival injection. Cephalalgia 25(4):317–320PubMedCrossRef
341.
go back to reference Schwaag S, Frese A, Husstedt IW, Evers S (2003) SUNCT syndrome: the first German case series. Cephalalgia 23(5):398–400PubMedCrossRef Schwaag S, Frese A, Husstedt IW, Evers S (2003) SUNCT syndrome: the first German case series. Cephalalgia 23(5):398–400PubMedCrossRef
342.
go back to reference Porta-Etessam J, Benito-Leon J, Martinez-Salio A, Berbel A (2002) Gabapentin in the treatment of SUNCT syndrome. Headache 42(6):523–524PubMedCrossRef Porta-Etessam J, Benito-Leon J, Martinez-Salio A, Berbel A (2002) Gabapentin in the treatment of SUNCT syndrome. Headache 42(6):523–524PubMedCrossRef
343.
go back to reference Graff-Radford SB (2000) SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 20(5):515–517PubMedCrossRef Graff-Radford SB (2000) SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 20(5):515–517PubMedCrossRef
344.
345.
346.
go back to reference Leone M, Rigamonti A, Usai S, Damico D, Grazzi L, Bussone G (2000) Two new SUNCT cases responsive to lamotrigine. Cephalalgia 20(9):845–847PubMedCrossRef Leone M, Rigamonti A, Usai S, Damico D, Grazzi L, Bussone G (2000) Two new SUNCT cases responsive to lamotrigine. Cephalalgia 20(9):845–847PubMedCrossRef
347.
go back to reference D’Andrea G, Granella F, Ghiotto N, Nappi G (2001) Lamotrigine in the treatment of SUNCT syndrome. Neurology 57(9):1723–1725PubMedCrossRef D’Andrea G, Granella F, Ghiotto N, Nappi G (2001) Lamotrigine in the treatment of SUNCT syndrome. Neurology 57(9):1723–1725PubMedCrossRef
348.
go back to reference Chakravarty A, Mukherjee A (2003) SUNCT syndrome responsive to lamotrigine: documentation of the first Indian case. Cephalalgia 23(6):474–475PubMedCrossRef Chakravarty A, Mukherjee A (2003) SUNCT syndrome responsive to lamotrigine: documentation of the first Indian case. Cephalalgia 23(6):474–475PubMedCrossRef
349.
go back to reference D’Andrea G, Granella F, Cadaldini M (1999) Possible usefulness of lamotrigine in the treatment of SUNCT syndrome. Neurology 53(7):1609PubMedCrossRef D’Andrea G, Granella F, Cadaldini M (1999) Possible usefulness of lamotrigine in the treatment of SUNCT syndrome. Neurology 53(7):1609PubMedCrossRef
350.
go back to reference Vikelis M, Xifaras M, Mitsikostas DD (2005) SUNCT syndrome in the elderly. Cephalalgia 25(11):1091–1092PubMedCrossRef Vikelis M, Xifaras M, Mitsikostas DD (2005) SUNCT syndrome in the elderly. Cephalalgia 25(11):1091–1092PubMedCrossRef
351.
go back to reference Piovesan EJ, Siow C, Kowacs PA, Werneck LC (2003) Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years. Arq Neuropsiquiatr 61(3A):691–694PubMedCrossRef Piovesan EJ, Siow C, Kowacs PA, Werneck LC (2003) Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years. Arq Neuropsiquiatr 61(3A):691–694PubMedCrossRef
352.
go back to reference Malik K, Rizvi S, Vaillancourt PD (2002) The SUNCT syndrome: successfully treated with lamotrigine. Pain Med 3(2):167–168PubMedCrossRef Malik K, Rizvi S, Vaillancourt PD (2002) The SUNCT syndrome: successfully treated with lamotrigine. Pain Med 3(2):167–168PubMedCrossRef
353.
go back to reference Narbone MC, Gangemi S, Abbate M (2005) A case of SUNCT syndrome responsive to verapamil. Cephalalgia 25(6):476–478PubMedCrossRef Narbone MC, Gangemi S, Abbate M (2005) A case of SUNCT syndrome responsive to verapamil. Cephalalgia 25(6):476–478PubMedCrossRef
354.
go back to reference Kuhn J, Vosskaemper M, Bewermeyer H (2005) SUNCT syndrome: a possible bilateral case responding to topiramate. Neurology 64(12):2159PubMedCrossRef Kuhn J, Vosskaemper M, Bewermeyer H (2005) SUNCT syndrome: a possible bilateral case responding to topiramate. Neurology 64(12):2159PubMedCrossRef
355.
go back to reference Trauninger A, Alkonyi B, Kovács N, Komoly S, Pfund Z (2010) Methylprednisolone therapy for short-term prevention of SUNCT syndrome. Cephalalgia 30(6):735–739PubMed Trauninger A, Alkonyi B, Kovács N, Komoly S, Pfund Z (2010) Methylprednisolone therapy for short-term prevention of SUNCT syndrome. Cephalalgia 30(6):735–739PubMed
356.
go back to reference Marziniak M, Breyer R, Evers S (2009) SUNCT syndrome successfully treated with the combination of oxcarbazepine and gabapentin. Pain Med 10(8):1497–1500PubMedCrossRef Marziniak M, Breyer R, Evers S (2009) SUNCT syndrome successfully treated with the combination of oxcarbazepine and gabapentin. Pain Med 10(8):1497–1500PubMedCrossRef
357.
go back to reference Arroyo AM, Durán XR, Beldarrain MG, Pinedo A, García-Moncó JC (2010) Response to intravenous lidocaine in a patient with SUNCT syndrome. Cephalalgia 30(1):110–112PubMed Arroyo AM, Durán XR, Beldarrain MG, Pinedo A, García-Moncó JC (2010) Response to intravenous lidocaine in a patient with SUNCT syndrome. Cephalalgia 30(1):110–112PubMed
358.
go back to reference Friedman D, Feldon S, Holloway R, Fisher S (2009) Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department. Headache 49(8):1163–1173PubMedCrossRef Friedman D, Feldon S, Holloway R, Fisher S (2009) Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department. Headache 49(8):1163–1173PubMedCrossRef
359.
go back to reference Davis CP, Torre PR, Schafer NC, Dave B, Bass B Jr (1993) Ketorolac as a rapid and effective treatment of migraine headache: evaluations by patients. Am J Emerg Med 11(6):573–575PubMedCrossRef Davis CP, Torre PR, Schafer NC, Dave B, Bass B Jr (1993) Ketorolac as a rapid and effective treatment of migraine headache: evaluations by patients. Am J Emerg Med 11(6):573–575PubMedCrossRef
360.
go back to reference Diener HC, Lampl C, Reimnitz P, Voelker M (2006) Aspirin in the treatment of acute migraine attacks. Expert Rev Neurother 6(4):563–573 (review)PubMedCrossRef Diener HC, Lampl C, Reimnitz P, Voelker M (2006) Aspirin in the treatment of acute migraine attacks. Expert Rev Neurother 6(4):563–573 (review)PubMedCrossRef
361.
go back to reference Bigal ME, Bordini CA, Tepper SJ, Speciali JG (2002) Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache 42:862–871PubMedCrossRef Bigal ME, Bordini CA, Tepper SJ, Speciali JG (2002) Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache 42:862–871PubMedCrossRef
362.
go back to reference Akpunonu BE, Mutgi AB, Federman DJ, Volinsky FG, Brickman K, Davis RL, Gilbert C, Asgharnejad M (1995) Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Ann Emerg Med 25(4):464–469PubMedCrossRef Akpunonu BE, Mutgi AB, Federman DJ, Volinsky FG, Brickman K, Davis RL, Gilbert C, Asgharnejad M (1995) Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Ann Emerg Med 25(4):464–469PubMedCrossRef
363.
go back to reference Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT (2010) A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med 56(1):1–6 (epub 2010 Jan 4)PubMedCrossRef Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT (2010) A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med 56(1):1–6 (epub 2010 Jan 4)PubMedCrossRef
364.
go back to reference Mellick LB, Mellick GA (2004) Treatment of primary headache in the emergency department. Headache 44(8):840–841PubMedCrossRef Mellick LB, Mellick GA (2004) Treatment of primary headache in the emergency department. Headache 44(8):840–841PubMedCrossRef
365.
go back to reference Mauskop A, Altura BT, Cracco RQ et al (1996) Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 36(3):1541–1560CrossRef Mauskop A, Altura BT, Cracco RQ et al (1996) Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 36(3):1541–1560CrossRef
366.
go back to reference Coppola M, Yealy DM, Leibold RA (1995) Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 26(5):541–546PubMedCrossRef Coppola M, Yealy DM, Leibold RA (1995) Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 26(5):541–546PubMedCrossRef
367.
go back to reference Friedman BW, Esses D, Solorzano C, Dua N, Greenwald P, Radulescu R, Chang E, Hochberg M, Campbell C, Aghera A, Valentin T, Paternoster J, Bijur P, Lipton RB, Gallagher EJ (2008) A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med 52(4):399–406 (epub 2007 Nov 19)PubMedCrossRef Friedman BW, Esses D, Solorzano C, Dua N, Greenwald P, Radulescu R, Chang E, Hochberg M, Campbell C, Aghera A, Valentin T, Paternoster J, Bijur P, Lipton RB, Gallagher EJ (2008) A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med 52(4):399–406 (epub 2007 Nov 19)PubMedCrossRef
368.
go back to reference Tanen DA, Miller S, French T, Riffenburgh RH (2003) Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 41(6):847–853PubMedCrossRef Tanen DA, Miller S, French T, Riffenburgh RH (2003) Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 41(6):847–853PubMedCrossRef
369.
go back to reference Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH (2008) The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med 52(6):705–713 (epub 2008 Jul 16)PubMedCentralPubMedCrossRef Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH (2008) The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med 52(6):705–713 (epub 2008 Jul 16)PubMedCentralPubMedCrossRef
370.
go back to reference Baden EY, Hunter CJ (2006) Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: a randomized, double-blind, placebo-controlled clinical trial. CJEM 8:393–400PubMed Baden EY, Hunter CJ (2006) Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: a randomized, double-blind, placebo-controlled clinical trial. CJEM 8:393–400PubMed
371.
go back to reference Innes GD, Macphail I, Dillon EC, Metcalfe C, Gao M (1999) Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM 1:26–33PubMed Innes GD, Macphail I, Dillon EC, Metcalfe C, Gao M (1999) Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM 1:26–33PubMed
372.
go back to reference Donaldson D, Sundermann R, Jackson R, Bastani A (2008) Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial. Am J Emerg Med 26:124–130PubMedCrossRef Donaldson D, Sundermann R, Jackson R, Bastani A (2008) Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial. Am J Emerg Med 26:124–130PubMedCrossRef
373.
go back to reference Rowe BH, Colman I, Edmonds ML, Blitz S, Walker A, Wiens S (2008) Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache 48(3):333–340 (epub 2007 Nov 28)PubMedCrossRef Rowe BH, Colman I, Edmonds ML, Blitz S, Walker A, Wiens S (2008) Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache 48(3):333–340 (epub 2007 Nov 28)PubMedCrossRef
374.
go back to reference Cicek M, Karcioglu O, Parlak I, Ozturk V, Duman O, Serinken M, Guryay M (2004) Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emerg Med J 21(3):323–326PubMedCentralPubMedCrossRef Cicek M, Karcioglu O, Parlak I, Ozturk V, Duman O, Serinken M, Guryay M (2004) Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emerg Med J 21(3):323–326PubMedCentralPubMedCrossRef
375.
go back to reference Bigal ME, Bordini CA, Speciali JG (2002) Intravenous chlorpromazine in the acute treatment of episodic tension-type headache: a randomized, placebo controlled, double-blind study. Arq Neuropsiquiatr 60(3-A):537–541PubMedCrossRef Bigal ME, Bordini CA, Speciali JG (2002) Intravenous chlorpromazine in the acute treatment of episodic tension-type headache: a randomized, placebo controlled, double-blind study. Arq Neuropsiquiatr 60(3-A):537–541PubMedCrossRef
377.
go back to reference MacGregor EA (2007) Migraine in pregnancy and lactation: a clinical review. J Fam Plann Reprod Health Care 33(2):83–93 (review)PubMedCrossRef MacGregor EA (2007) Migraine in pregnancy and lactation: a clinical review. J Fam Plann Reprod Health Care 33(2):83–93 (review)PubMedCrossRef
378.
go back to reference Allais G, Gabellari IC, Borgogno P, De Lorenzo C, Benedetto C (2010) The risks of women with migraine during pregnancy. Neurol Sci 31(Suppl 1):S59–S61 (review)PubMedCrossRef Allais G, Gabellari IC, Borgogno P, De Lorenzo C, Benedetto C (2010) The risks of women with migraine during pregnancy. Neurol Sci 31(Suppl 1):S59–S61 (review)PubMedCrossRef
379.
go back to reference Contag SA, Bushnell C (2010) Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol 22(6):437–445PubMedCrossRef Contag SA, Bushnell C (2010) Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol 22(6):437–445PubMedCrossRef
380.
go back to reference Cassina M, Di Gianantonio E, Toldo I, Battistella PA, Clementi M (2010) Migraine therapy during pregnancy and lactation. Expert Opin Drug Saf 9(6):937–948PubMedCrossRef Cassina M, Di Gianantonio E, Toldo I, Battistella PA, Clementi M (2010) Migraine therapy during pregnancy and lactation. Expert Opin Drug Saf 9(6):937–948PubMedCrossRef
381.
go back to reference Brandes JL (2008) Headache related to pregnancy: management of migraine and migraine headache in pregnancy. Curr Treat Options Neurol 10(1):12–19PubMedCrossRef Brandes JL (2008) Headache related to pregnancy: management of migraine and migraine headache in pregnancy. Curr Treat Options Neurol 10(1):12–19PubMedCrossRef
382.
383.
go back to reference Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J (2000) Pregnancy outcome following prescription for sumatriptan. Headache 40:20–24PubMedCrossRef Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J (2000) Pregnancy outcome following prescription for sumatriptan. Headache 40:20–24PubMedCrossRef
384.
go back to reference Källen B, Lygner PE (2001) Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 41:351–356PubMedCrossRef Källen B, Lygner PE (2001) Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 41:351–356PubMedCrossRef
385.
go back to reference Fox AW, Chambers CD, Anderson PO, Diamond ML, Spierings EL (2002) Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42:8–15PubMedCrossRef Fox AW, Chambers CD, Anderson PO, Diamond ML, Spierings EL (2002) Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42:8–15PubMedCrossRef
386.
387.
go back to reference Fox AW (2004) Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure. Headache 44(3):293–294PubMedCrossRef Fox AW (2004) Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure. Headache 44(3):293–294PubMedCrossRef
388.
389.
go back to reference Cunnington M, Ephross S, Churchill P (2009) The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache 49(10):1414–1422 (epub 2009 Oct 5)PubMedCrossRef Cunnington M, Ephross S, Churchill P (2009) The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache 49(10):1414–1422 (epub 2009 Oct 5)PubMedCrossRef
390.
go back to reference Blair EM, Nelson KB (2011) Migraine and preterm birth. J Perinatol 31(6):434–439 Blair EM, Nelson KB (2011) Migraine and preterm birth. J Perinatol 31(6):434–439
391.
go back to reference Nezvalová-Henriksen K, Spigset O, Nordeng H (2010) Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 50(4):563–575 (epub 2010 Jan 28)PubMedCrossRef Nezvalová-Henriksen K, Spigset O, Nordeng H (2010) Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 50(4):563–575 (epub 2010 Jan 28)PubMedCrossRef
392.
go back to reference Kurth T, Hernandez-Diaz S (2010) Commentary: triptan use during pregnancy: a safe choice? Headache 50(4):576–578PubMedCrossRef Kurth T, Hernandez-Diaz S (2010) Commentary: triptan use during pregnancy: a safe choice? Headache 50(4):576–578PubMedCrossRef
393.
go back to reference Marcus DA (2008) Managing headache during pregnancy and lactation. Expert Rev Neurother 8(3):385–395 (review)PubMedCrossRef Marcus DA (2008) Managing headache during pregnancy and lactation. Expert Rev Neurother 8(3):385–395 (review)PubMedCrossRef
394.
go back to reference Fox AW, Diamond ML, Spierings EL (2005) Migraine during pregnancy: options for therapy. CNS Drugs 19(6):465–481PubMedCrossRef Fox AW, Diamond ML, Spierings EL (2005) Migraine during pregnancy: options for therapy. CNS Drugs 19(6):465–481PubMedCrossRef
395.
go back to reference Diav-Citrin O, Shechtman S, Bar-Oz B, Cantrell D, Arnon J, Ornoy A (2008) Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs 22(4):325–334PubMedCrossRef Diav-Citrin O, Shechtman S, Bar-Oz B, Cantrell D, Arnon J, Ornoy A (2008) Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs 22(4):325–334PubMedCrossRef
396.
397.
go back to reference Hunt SJ, Morrow JI (2005) Safety of antiepileptic drugs during pregnancy. Expert Opin Drug Saf 4(5):869–877 (review)PubMedCrossRef Hunt SJ, Morrow JI (2005) Safety of antiepileptic drugs during pregnancy. Expert Opin Drug Saf 4(5):869–877 (review)PubMedCrossRef
398.
go back to reference Lucas S (2009) Medication use in the treatment of migraine during pregnancy and lactation. Curr Pain Headache Rep 13(5):392–398 (review)PubMedCrossRef Lucas S (2009) Medication use in the treatment of migraine during pregnancy and lactation. Curr Pain Headache Rep 13(5):392–398 (review)PubMedCrossRef
399.
go back to reference Gladstone JP, Eross EJ, Dodick DW (2004) Migraine in special populations. Treatment strategies for children and adolescents, pregnant women, and the elderly. Postgrad Med 115(4):39–44, 47–50 (review) Gladstone JP, Eross EJ, Dodick DW (2004) Migraine in special populations. Treatment strategies for children and adolescents, pregnant women, and the elderly. Postgrad Med 115(4):39–44, 47–50 (review)
400.
go back to reference Jürgens TP, Schaefer C, May A (2009) Treatment of cluster headache in pregnancy and lactation. Cephalalgia 29(4):391–400 (epub 2009 Jan 19)PubMedCrossRef Jürgens TP, Schaefer C, May A (2009) Treatment of cluster headache in pregnancy and lactation. Cephalalgia 29(4):391–400 (epub 2009 Jan 19)PubMedCrossRef
401.
go back to reference Giraud P, Chauvet S (2009) Cluster headache during pregnancy: case report and literature review. Headache 49(1):136–139PubMedCrossRef Giraud P, Chauvet S (2009) Cluster headache during pregnancy: case report and literature review. Headache 49(1):136–139PubMedCrossRef
402.
go back to reference Sarchielli P, Mancini ML, Calabresi P (2006) Practical considerations for the treatment of elderly patients with migraine. Drugs Aging 23(2):131–155CrossRef Sarchielli P, Mancini ML, Calabresi P (2006) Practical considerations for the treatment of elderly patients with migraine. Drugs Aging 23(2):131–155CrossRef
403.
go back to reference Martin VT, Goldstein JA (2005) Evaluating the safety and tolerability profile of acute treatments for migraine. Am J Med 118(Suppl 1):36S–44SPubMed Martin VT, Goldstein JA (2005) Evaluating the safety and tolerability profile of acute treatments for migraine. Am J Med 118(Suppl 1):36S–44SPubMed
404.
go back to reference Zanchin G, Maggioni F, Granella F, Rossi P, Falco L, Manzoni GC (2001) Self-administered pain-relieving manoeuvres in primary headaches. Cephalalgia 21(7):718–726PubMedCrossRef Zanchin G, Maggioni F, Granella F, Rossi P, Falco L, Manzoni GC (2001) Self-administered pain-relieving manoeuvres in primary headaches. Cephalalgia 21(7):718–726PubMedCrossRef
405.
go back to reference Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W (2003) Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. J Intern Med 253(2):181–188PubMedCrossRef Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W (2003) Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. J Intern Med 253(2):181–188PubMedCrossRef
406.
go back to reference Lipton RB, Dodick DW, Silberstein SD, Saper JL, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ (2010) Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 9:373–380PubMedCrossRef Lipton RB, Dodick DW, Silberstein SD, Saper JL, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ (2010) Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 9:373–380PubMedCrossRef
407.
go back to reference Caputi CA, Firetto V (1997) Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 37:174–179PubMedCrossRef Caputi CA, Firetto V (1997) Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 37:174–179PubMedCrossRef
408.
go back to reference Nestoriuc Y, Martin A (2007) Efficacy of biofeedback for migraine: a meta-analysis. Pain 128(1–2):111–127 (epub 2006 Nov)PubMedCrossRef Nestoriuc Y, Martin A (2007) Efficacy of biofeedback for migraine: a meta-analysis. Pain 128(1–2):111–127 (epub 2006 Nov)PubMedCrossRef
409.
go back to reference Mullally WJ, Hall K, Goldstein R (2009) Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician 12(6):1005–1011PubMed Mullally WJ, Hall K, Goldstein R (2009) Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician 12(6):1005–1011PubMed
410.
go back to reference Wang LP, Zhang XZ, Guo J, Liu HL, Zhang Y, Liu CZ, Yi JH, Wang LP, Zhao JP, Li SS (2011) Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial. Pain 152(8):1864–1871 (epub 2011 May 26)PubMedCrossRef Wang LP, Zhang XZ, Guo J, Liu HL, Zhang Y, Liu CZ, Yi JH, Wang LP, Zhao JP, Li SS (2011) Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial. Pain 152(8):1864–1871 (epub 2011 May 26)PubMedCrossRef
411.
go back to reference Rigatelli G, Dell’Avvocata F, Ronco F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Rigatelli G, Chen JP (2010) Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv 3(3):282–287PubMedCrossRef Rigatelli G, Dell’Avvocata F, Ronco F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Rigatelli G, Chen JP (2010) Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv 3(3):282–287PubMedCrossRef
412.
go back to reference Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A (2008) Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117(11):1397–1404 (epub 2008 Mar 3)PubMedCrossRef Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A (2008) Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117(11):1397–1404 (epub 2008 Mar 3)PubMedCrossRef
413.
go back to reference Nestoriuc Y, Rief W, Martin A (2008) Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. J Consult Clin Psychol 76(3):379–396PubMedCrossRef Nestoriuc Y, Rief W, Martin A (2008) Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. J Consult Clin Psychol 76(3):379–396PubMedCrossRef
414.
go back to reference De Tommaso M, Shevel E, Pecoraro C, Sardaro M, Divenere D, Di Fruscolo O, Lamberti P, Livrea P (2006) Intra-oral orthosis vs amitriptyline in chronic tension-type headache: a clinical and laser evoked potentials study. Head Face Med 2:15PubMedCentralPubMedCrossRef De Tommaso M, Shevel E, Pecoraro C, Sardaro M, Divenere D, Di Fruscolo O, Lamberti P, Livrea P (2006) Intra-oral orthosis vs amitriptyline in chronic tension-type headache: a clinical and laser evoked potentials study. Head Face Med 2:15PubMedCentralPubMedCrossRef
415.
go back to reference Holroyd KA, O’Donnel FJ, Stensland M, Lipchick GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA 285(17):2208–2214PubMedCentralPubMedCrossRef Holroyd KA, O’Donnel FJ, Stensland M, Lipchick GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA 285(17):2208–2214PubMedCentralPubMedCrossRef
416.
go back to reference Altieri M, Di Giambattista R, Di Clemente L (2009) Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study. Cephalalgia 29:293–299PubMedCrossRef Altieri M, Di Giambattista R, Di Clemente L (2009) Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study. Cephalalgia 29:293–299PubMedCrossRef
417.
go back to reference Anderson E, Seniscal C (2006) A comparison of selected osteopathic treatment and relaxation for tension-type headaches. Headache 46(8):1273–1280PubMedCrossRef Anderson E, Seniscal C (2006) A comparison of selected osteopathic treatment and relaxation for tension-type headaches. Headache 46(8):1273–1280PubMedCrossRef
418.
go back to reference Ernst E (2004) Manual therapies for pain control: chiropractic and massage. Clin J Pain 20(1):8–12 (review)PubMedCrossRef Ernst E (2004) Manual therapies for pain control: chiropractic and massage. Clin J Pain 20(1):8–12 (review)PubMedCrossRef
419.
go back to reference Fernandez-de-las-Penas C, Alonso-Blanco C, San-Roman J, Miangollara-Page JC (2006) Methodological quality of randomized controlled trials of spinal manipulation and mobilization in TTH, migraine, and cervicogenic headache. J Orthop Sports Phys Ther 36(3):160–169PubMedCrossRef Fernandez-de-las-Penas C, Alonso-Blanco C, San-Roman J, Miangollara-Page JC (2006) Methodological quality of randomized controlled trials of spinal manipulation and mobilization in TTH, migraine, and cervicogenic headache. J Orthop Sports Phys Ther 36(3):160–169PubMedCrossRef
420.
go back to reference Söderberg E, Carlsson J, Stener-Victorin E (2006) Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia 26(11):1320–1329PubMedCrossRef Söderberg E, Carlsson J, Stener-Victorin E (2006) Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia 26(11):1320–1329PubMedCrossRef
421.
go back to reference Shankland WE (2002) Nociceptive trigeminal inhibition-tension suppression system: amethod of preventing migraine and tension headaches. Compend Contin Educ Dent 23:105–108PubMed Shankland WE (2002) Nociceptive trigeminal inhibition-tension suppression system: amethod of preventing migraine and tension headaches. Compend Contin Educ Dent 23:105–108PubMed
422.
go back to reference Bronfort G, Nilsson N, Haas M, EvansR, Goldsmith CH, Assendelft WJ, Bouter LM (2004) Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev (3):CD001878 (review) Bronfort G, Nilsson N, Haas M, EvansR, Goldsmith CH, Assendelft WJ, Bouter LM (2004) Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev (3):CD001878 (review)
423.
go back to reference Leone M, Franzini A, Broggi G, Bussone G (2006) Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology 67(1):150–152PubMedCrossRef Leone M, Franzini A, Broggi G, Bussone G (2006) Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology 67(1):150–152PubMedCrossRef
424.
go back to reference Franzini A, Leone M, Messina G, Cordella R, Marras C, Bussone G, Broggi G (2008) Neuromodulation in treatment of refractory headaches. Neurol Sci 29(Suppl 1):S65–S68PubMedCrossRef Franzini A, Leone M, Messina G, Cordella R, Marras C, Bussone G, Broggi G (2008) Neuromodulation in treatment of refractory headaches. Neurol Sci 29(Suppl 1):S65–S68PubMedCrossRef
425.
go back to reference Fontaine D, Lazorthes Y, Mertens P, Blond S, Géraud G, Fabre N, Navez M, Lucas C, Dubois F, Gonfrier S, Paquis P, Lantéri-Minet M (2010) Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain 11(1):23–31 (comment in J Headache Pain 11(1):21–22, 2010)PubMedCentralPubMedCrossRef Fontaine D, Lazorthes Y, Mertens P, Blond S, Géraud G, Fabre N, Navez M, Lucas C, Dubois F, Gonfrier S, Paquis P, Lantéri-Minet M (2010) Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain 11(1):23–31 (comment in J Headache Pain 11(1):21–22, 2010)PubMedCentralPubMedCrossRef
426.
go back to reference Bartsch T, Paemeleire K, Goadsby PJ (2009) Neurostimulation approaches to primary headache disorders. Curr Opin Neurol 22:262–268PubMedCrossRef Bartsch T, Paemeleire K, Goadsby PJ (2009) Neurostimulation approaches to primary headache disorders. Curr Opin Neurol 22:262–268PubMedCrossRef
427.
go back to reference Castien RF, van der Windt DA, Grooten A, Dekker J (2011) Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial. Cephalalgia 31(2):133–143 (epub 2010 Jul 20)PubMedCrossRef Castien RF, van der Windt DA, Grooten A, Dekker J (2011) Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial. Cephalalgia 31(2):133–143 (epub 2010 Jul 20)PubMedCrossRef
428.
go back to reference Lipton RB, Pearlman SH (2010) Transcranial magnetic stimulation in the treatment of migraine. Neurotherapeutics 7:204–212PubMedCrossRef Lipton RB, Pearlman SH (2010) Transcranial magnetic stimulation in the treatment of migraine. Neurotherapeutics 7:204–212PubMedCrossRef
429.
go back to reference Calhoun AH, Ford S (2007) Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache 47:1178–1183PubMedCrossRef Calhoun AH, Ford S (2007) Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache 47:1178–1183PubMedCrossRef
430.
go back to reference Pieterse H, Kuster JA, Van Bortel LM (2007) Is the Migraid device an asset in the non-pharmacologic treatment of migraine? Acta Neurol Belg 107(2):40–46PubMed Pieterse H, Kuster JA, Van Bortel LM (2007) Is the Migraid device an asset in the non-pharmacologic treatment of migraine? Acta Neurol Belg 107(2):40–46PubMed
431.
go back to reference Mongini F, Ciccone G, Rota E, Ferrero L, Ugolini A, Evangelista A, Ceccarelli M, Galassi C (2008) Effectiveness of an educational and physical programme in reducing headache, neck and shoulder pain: a workplace controlled trial. Cephalalgia 28(5):541–552PubMedCrossRef Mongini F, Ciccone G, Rota E, Ferrero L, Ugolini A, Evangelista A, Ceccarelli M, Galassi C (2008) Effectiveness of an educational and physical programme in reducing headache, neck and shoulder pain: a workplace controlled trial. Cephalalgia 28(5):541–552PubMedCrossRef
432.
go back to reference Stokes DA, Lappin MS (2010) Neurofeedback and biofeedback with 37 migraineur: a clinical outcome study. Behav Brain Funct 2:6–9 Stokes DA, Lappin MS (2010) Neurofeedback and biofeedback with 37 migraineur: a clinical outcome study. Behav Brain Funct 2:6–9
433.
go back to reference John PJ, Sharma N, Sharma CM, Kankane A (2007) Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache 47(5):654–661PubMedCrossRef John PJ, Sharma N, Sharma CM, Kankane A (2007) Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache 47(5):654–661PubMedCrossRef
434.
go back to reference Nickel A, Hillecke T, Argstatter H, Volker, Bolay Y (2005) Outcome research in music therapy. A step on the long road to an evidence 7-based treatment. Ann N Y Acad Sci 1060:283–293PubMedCrossRef Nickel A, Hillecke T, Argstatter H, Volker, Bolay Y (2005) Outcome research in music therapy. A step on the long road to an evidence 7-based treatment. Ann N Y Acad Sci 1060:283–293PubMedCrossRef
435.
go back to reference Andrasik F (2007) What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci 28(suppl 2):570–577 Andrasik F (2007) What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci 28(suppl 2):570–577
436.
go back to reference Grazzi L, Andrasik F, D’Amico D, Leone M, Usai S, Kass SJ, Bussone G (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42(6):483–490PubMedCrossRef Grazzi L, Andrasik F, D’Amico D, Leone M, Usai S, Kass SJ, Bussone G (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42(6):483–490PubMedCrossRef
437.
go back to reference Symvoulakis EK, Clark LV, Dowson AJ, Jones R, Ridsdale L (2007) Headache: a “suitable case” for behavioural treatment in primary care? Br J Gen Pract 57:231–237PubMedCentralPubMed Symvoulakis EK, Clark LV, Dowson AJ, Jones R, Ridsdale L (2007) Headache: a “suitable case” for behavioural treatment in primary care? Br J Gen Pract 57:231–237PubMedCentralPubMed
438.
go back to reference Rains JC, Poceta S (2006) Headache and sleep disorders: review and clinical implications for headache management. Headache 46:1344–1363PubMedCrossRef Rains JC, Poceta S (2006) Headache and sleep disorders: review and clinical implications for headache management. Headache 46:1344–1363PubMedCrossRef
439.
go back to reference Maher C (2001) A randomized controlled trial of chiropractic spinal manipulative therapy for migraines. J Manip Phisiol Ther 24(2):143–144CrossRef Maher C (2001) A randomized controlled trial of chiropractic spinal manipulative therapy for migraines. J Manip Phisiol Ther 24(2):143–144CrossRef
440.
go back to reference Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV (1998) The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. J Manip Physiol Ther 21(8):511–519 Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV (1998) The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. J Manip Physiol Ther 21(8):511–519
441.
go back to reference Sandor PS, Afra J (2005) Nonpharmacological treatment of migraine. Curr Pain Headache Rep 9(3):202–205PubMedCrossRef Sandor PS, Afra J (2005) Nonpharmacological treatment of migraine. Curr Pain Headache Rep 9(3):202–205PubMedCrossRef
442.
443.
go back to reference Lawler SP, Cameron LD (2006) A randomized, controlled trial of massage therapy as a treatment for migraine. Ann Behav Med 32(1):50–59PubMedCrossRef Lawler SP, Cameron LD (2006) A randomized, controlled trial of massage therapy as a treatment for migraine. Ann Behav Med 32(1):50–59PubMedCrossRef
444.
go back to reference Marcus DA, Scharff L, Mercer S, Turk DC (1998) Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia 18(5):266–272 (discussion 242)PubMedCrossRef Marcus DA, Scharff L, Mercer S, Turk DC (1998) Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia 18(5):266–272 (discussion 242)PubMedCrossRef
445.
go back to reference Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch HJ, Zenz M, Meinert R (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5(4):310–316PubMedCrossRef Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch HJ, Zenz M, Meinert R (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5(4):310–316PubMedCrossRef
446.
go back to reference Teepker M, Hötzel J, Timmesfeld N, Reis J, Mylius V, Haag A, Oertel WH, Rosenow F, Schepelmann K (2010) Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia 30(2):137–144PubMed Teepker M, Hötzel J, Timmesfeld N, Reis J, Mylius V, Haag A, Oertel WH, Rosenow F, Schepelmann K (2010) Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia 30(2):137–144PubMed
447.
go back to reference Lockett DM, Campbell JF (1992) The effects of aerobic exercise on migraine. Headache 32(1):50–54 (erratum in: Headache Apr;32(4):187)PubMedCrossRef Lockett DM, Campbell JF (1992) The effects of aerobic exercise on migraine. Headache 32(1):50–54 (erratum in: Headache Apr;32(4):187)PubMedCrossRef
448.
go back to reference Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B (2010) Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia 30(7):829–837PubMedCentralPubMedCrossRef Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B (2010) Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia 30(7):829–837PubMedCentralPubMedCrossRef
449.
go back to reference Shevel E (2005) Craniomandibular muscles, intraoral orthoses and migraine. Expert Rev Neurother 5(3):371–377PubMedCrossRef Shevel E (2005) Craniomandibular muscles, intraoral orthoses and migraine. Expert Rev Neurother 5(3):371–377PubMedCrossRef
450.
go back to reference Oh MY, Ortega J, Bellotte JB, Whiting DM, Alo K (2004) Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a C1–2-3 subcutaneous paddle style electrode. A technical report. Neuromodulation 7:103–112PubMedCrossRef Oh MY, Ortega J, Bellotte JB, Whiting DM, Alo K (2004) Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a C1–2-3 subcutaneous paddle style electrode. A technical report. Neuromodulation 7:103–112PubMedCrossRef
451.
go back to reference Guyuron B, Kriegler JS, Davis J, Amini S (2011) Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg 127(2):603–608 Guyuron B, Kriegler JS, Davis J, Amini S (2011) Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg 127(2):603–608
452.
go back to reference Granato A, Chiodo Grandi F, Stokelj D, Musho S, Pizzolato G (2010) Acupunture in tension-type headache. Neuroepidemiology 35:160–162PubMedCrossRef Granato A, Chiodo Grandi F, Stokelj D, Musho S, Pizzolato G (2010) Acupunture in tension-type headache. Neuroepidemiology 35:160–162PubMedCrossRef
453.
go back to reference Biondi DM (2005) Physical treatments for headache: a structured review. Headache 45(6):738–746 (review)PubMedCrossRef Biondi DM (2005) Physical treatments for headache: a structured review. Headache 45(6):738–746 (review)PubMedCrossRef
454.
go back to reference Castien RF, van der Windt DA, Dekker J, Mutsaers B, Grooten A (2009) Effectiveness of manual therapy compared to usual care by the general practitioner for chronic tension-type headache: design of a randomised clinical trial. BMC Musculoskelet Disord 10:21PubMedCentralPubMedCrossRef Castien RF, van der Windt DA, Dekker J, Mutsaers B, Grooten A (2009) Effectiveness of manual therapy compared to usual care by the general practitioner for chronic tension-type headache: design of a randomised clinical trial. BMC Musculoskelet Disord 10:21PubMedCentralPubMedCrossRef
455.
go back to reference Grunnet-Nilsson N, Bove G (2000) Therapeutic manipulation of episodic TTH. A randomized, controlled clinical trial. Ugeskr laeger 162(2):174–177PubMed Grunnet-Nilsson N, Bove G (2000) Therapeutic manipulation of episodic TTH. A randomized, controlled clinical trial. Ugeskr laeger 162(2):174–177PubMed
456.
go back to reference Lenssinck ML, Damen L, Verhagen AP, Berger MY, Passchier J, Koes BW (2004) The effectiveness of physiotherapy and manipulation in patients with tension-type headache: a systematic review. Pain 112(3):381–388 (review)PubMedCrossRef Lenssinck ML, Damen L, Verhagen AP, Berger MY, Passchier J, Koes BW (2004) The effectiveness of physiotherapy and manipulation in patients with tension-type headache: a systematic review. Pain 112(3):381–388 (review)PubMedCrossRef
457.
go back to reference Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24(1):29–36PubMedCrossRef Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24(1):29–36PubMedCrossRef
458.
go back to reference van Ettekoven H, Lucas C (2006) Efficacy of physiotherapy including a craniocervical training program for TTH; a randomized clinical trial. Cephalalgia 26(8):983–991PubMedCrossRef van Ettekoven H, Lucas C (2006) Efficacy of physiotherapy including a craniocervical training program for TTH; a randomized clinical trial. Cephalalgia 26(8):983–991PubMedCrossRef
459.
go back to reference Keller E, Bzdek VM (1986) Effects of therapeutic touch on tension headache pain. Nurs Res 35(2):101–106PubMed Keller E, Bzdek VM (1986) Effects of therapeutic touch on tension headache pain. Nurs Res 35(2):101–106PubMed
460.
go back to reference Ekberg E, Vallon D, Nilner M (2002) Treatment outcome of headache after occlusal appliance therapy in a randomised controlled trial among patients with temporomandibular disorders of mainly arthrogenous origin. Swed Dent J 26(3):115–124PubMed Ekberg E, Vallon D, Nilner M (2002) Treatment outcome of headache after occlusal appliance therapy in a randomised controlled trial among patients with temporomandibular disorders of mainly arthrogenous origin. Swed Dent J 26(3):115–124PubMed
461.
go back to reference Ambrosini A, Vandenheede M, Rossi P et al (2005) Suboccipital injection with a mixture of rapid-and long-acting steroids in cluster headache: a double- blind placebo-controlled study. Pain 118:92–96PubMedCrossRef Ambrosini A, Vandenheede M, Rossi P et al (2005) Suboccipital injection with a mixture of rapid-and long-acting steroids in cluster headache: a double- blind placebo-controlled study. Pain 118:92–96PubMedCrossRef
462.
go back to reference Donnet A, Tamura M, Valide D, Regis J (2006) Trigeminal nerve radiosurgical treatment in intractable chronic cluster headache: unexpected high toxicity. Neurosurgery 59(6):1252–1257PubMedCrossRef Donnet A, Tamura M, Valide D, Regis J (2006) Trigeminal nerve radiosurgical treatment in intractable chronic cluster headache: unexpected high toxicity. Neurosurgery 59(6):1252–1257PubMedCrossRef
463.
go back to reference Kano H, Kondziolka D, Mathieu D, Stafford SL, Flannery TJ, Niranjan A, Pollock BE, Kaufmann AM, Flickinger JC, Lunsford LD (2011) Stereotactic radiosurgery for intractable cluster headache: an initial report from the North American Gamma Knife Consortium. J Neurosurg 114(6):1736–1743 (epub 2010 Apr 30)PubMedCrossRef Kano H, Kondziolka D, Mathieu D, Stafford SL, Flannery TJ, Niranjan A, Pollock BE, Kaufmann AM, Flickinger JC, Lunsford LD (2011) Stereotactic radiosurgery for intractable cluster headache: an initial report from the North American Gamma Knife Consortium. J Neurosurg 114(6):1736–1743 (epub 2010 Apr 30)PubMedCrossRef
464.
go back to reference Jarrar RG, Black DF, Dodick DW, Davis DH (2003) Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology 60(8):1360–1362PubMedCrossRef Jarrar RG, Black DF, Dodick DW, Davis DH (2003) Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology 60(8):1360–1362PubMedCrossRef
465.
go back to reference McClelland S 3rd, Tendulkar RD, Barnett GH, Neyman G, Suh JH (2006) Long-term results of radiosurgery for refractory cluster headache. Neurosurgery 59(6):1258–1262PubMed McClelland S 3rd, Tendulkar RD, Barnett GH, Neyman G, Suh JH (2006) Long-term results of radiosurgery for refractory cluster headache. Neurosurgery 59(6):1258–1262PubMed
466.
go back to reference McClelland S 3rd, Barnett GH, Neyman G, Suh JH (2007) Repeat trigeminal nerve radiosurgery for refractory cluster headache fails to provide long-term pain relief. Headache 47(2):298–300PubMedCrossRef McClelland S 3rd, Barnett GH, Neyman G, Suh JH (2007) Repeat trigeminal nerve radiosurgery for refractory cluster headache fails to provide long-term pain relief. Headache 47(2):298–300PubMedCrossRef
467.
go back to reference Taha JM, Tew JM Jr (1995) Long-term results of radiofrequency rhizotomy in the treatment of cluster headache. Headache 35(4):193–196PubMedCrossRef Taha JM, Tew JM Jr (1995) Long-term results of radiofrequency rhizotomy in the treatment of cluster headache. Headache 35(4):193–196PubMedCrossRef
468.
go back to reference Magis D, Allena M, Bolla M, Pasqua VD, Remacle JM, Schoenen J (2007) Occipital nerve stimulation for drug-resistant chronic cluster headache. A prospective pilot study. Lancet Neurol 6:314–321PubMedCrossRef Magis D, Allena M, Bolla M, Pasqua VD, Remacle JM, Schoenen J (2007) Occipital nerve stimulation for drug-resistant chronic cluster headache. A prospective pilot study. Lancet Neurol 6:314–321PubMedCrossRef
469.
go back to reference Burns B, Watkins L, Goadsby PJ (2009) Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 72:341–345PubMedCrossRef Burns B, Watkins L, Goadsby PJ (2009) Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 72:341–345PubMedCrossRef
470.
go back to reference Leone M, Franzini A, Cecchini AP, Brogli G, Bussone G (2010) Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord 3(3):187–195PubMedCentralPubMedCrossRef Leone M, Franzini A, Cecchini AP, Brogli G, Bussone G (2010) Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord 3(3):187–195PubMedCentralPubMedCrossRef
Metadata
Title
Italian guidelines for primary headaches: 2012 revised version
Authors
Paola Sarchielli
Franco Granella
Maria Pia Prudenzano
Luigi Alberto Pini
Vincenzo Guidetti
Giorgio Bono
Lorenzo Pinessi
Massimo Alessandri
Fabio Antonaci
Marcello Fanciullacci
Anna Ferrari
Mario Guazzelli
Giuseppe Nappi
Grazia Sances
Giorgio Sandrini
Lidia Savi
Cristina Tassorelli
Giorgio Zanchin
Publication date
01-05-2012
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 2/2012
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-012-0437-6